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Cell-matrix and cell-cell adhesion proteins are of great significance for many 
fundamental cellular processes such as survival, differentiation, spreading, adhesion, migration 
as well as oncogenic transformation.  In the present dissertation study, the role of different 
integrin-proximal protein complexes was investigated in vitro in cancer cells and in primary rat 
hepatocytes and in vivo in whole animals.   
First it was shown that migfilin, a newly identified cell-matrix adhesion protein, is also an 
important component of cell-cell junctions critical for the organization and strengthening of the 
adherens junctions.  Next, Ras-Suppressor-1 (RSU-1), which interacts with the focal adhesion 
protein PINCH, was shown to regulate cell spreading and adhesion, although the exact 
mechanism is yet unclear.   
Furthermore, the role of Integrin-Linked Kinase (ILK) was investigated in vitro in the 
model system of matrix-induced hepatocyte differentiation.  It was shown that ILK along with its 
binding partners PINCH and α-parvin are dramatically down-regulated during the matrix-
induced re-differentiation of hepatocytes.  Thus, ILK and its binding partners likely play an 
important role in matrix-induced-hepatocyte differentiation. 
Finally, the role of ILK was examined in vivo by removing the protein from the whole 
animal or specifically from the liver.  First ILK was removed from ILK-floxed mice following 
Cre-recombinase-adenoviral injections giving rise to animals with fulminant hepatitis 
characterized by massive apoptosis, abnormal mitoses, fatty change and necrosis in the liver. 
Then, ILK-floxed animals were crossbred with alpha-fetoprotein(AFP)-albumin, albumin, or 
Foxa3-Cre transgenic mice and thus ILK was genetically removed specifically from the liver.  In 
all cases, the livers of the animals had disorganized liver architecture, absence of hepatocyte 
plates, increased fibrosis, absence of microvilli in the canaliculi, different degrees of 
malformations in the biliary system, apoptosis and compensatory proliferation.  The present 
findings therefore, clearly show that ILK is critical for hepatocyte differentiation and survival 
 iii 
and more importantly, this holds true in vivo where ILK is crucial for the maintainance of normal 
liver architecture and function. 
Thus, the present dissertation work highlights the importance of cell-matrix adhesion 
proteins in vitro and in vivo and enhances the scientific knowledge in the field of molecular, 
cellular, hepatocyte and liver biology.  
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1.0  PART I:  INTRODUCTION TO CELL MATRIX ADHESIONS 
One of the major prerequisites for the proper function of cells within a tissue is the formation of 
contacts with the surrounding extracellular matrix (ECM) and the neighboring cells. The 
interaction between cells and various components of the ECM is of vital importance for a 
number of cellular processes such as cell survival, proliferation, differentiation, cell shape 
modulation, actin organization, migration, and gene expression.  Over the last two decades, 
exciting progress has been made in understanding the general molecular organization, assembly 
and functions of the cell-ECM adhesions.  Meanwhile, the complexity of cell-ECM adhesion 
structures in different developmental stages as well as various tissues and organs has been well 
appreciated.   
 
Integrins are heterodimeric, transmembrane glycoprotein receptors that are primarily 
responsible for mediating cell-ECM interactions (Hynes, 2002).  They interact with specific 
components of the ECM (collagen, fibronectin, vitronectin, laminin, etc.) via the extracellular 
domains and link them to the intracellular cytoskeletal and signaling complexes via the 
interactions of their cytoplasmic domains and multiple receptor-proximal cytoplasmic proteins. 
Apart from mediating the physical connection between ECM components and the actin 
cytoskeleton, integrins mediate bi-directional transduction of signals between the ECM and the 
intracellular compartment.  Integrins can therefore be activated in two ways; either as a result of 
their detection of changes in the microenvironment of the cell (outside-in signaling) or in 
response to signals that originate from the inner compartment of the cell (inside-out signaling) 
(Geiger et al., 2001; (Hynes, 2002).  The “outside-in signaling” of integrins begins with the 
binding of the ECM ligands to integrins and it is followed by clustering of integrins and the 
recruitment of actin filaments and signaling complexes to the cytoplasmic domain of integrins 
(Hynes, 2002). These initial complexes, which in cultured cells were often referred as “focal 
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complexes”, will in turn give rise to mature structures (often referred as focal adhesions (FAs) in 
cultured cells) that consist of larger and more complicated protein assemblies.  
 
The connection of many of the integrin-associated proteins with the actin cytoskeleton is 
of great significance for the fate of the cell.  It allows the cells to adhere properly to the ECM, 
modulate their shape via the connections to the cytoskeleton and acquire certain morphology. 
Additionally, this connection facilitates the transduction of extracellular signals to the interior of 
the cell, enabling it to respond appropriately by moving, changing morphology, differentiating or 
coordinating several other functions. 
 
At the molecular level, most of the integrin-associated molecules in FAs are 
multifunctional (Brakebusch and Fassler, 2003); Burridge and Chrzanowska-Wodnicka, 1996; 
Calderwood et al., 2000; Geiger et al., 2001; Zamir and Geiger, 2001). They associate with 
integrins and actin cytoskeleton.  In addition, they serve as scaffolds for the attachment of 
enzymes such as kinases and phosphatases that modify and regulate these complex interactions.  
Currently, more than sixty FA proteins including talin, α-actinin, filamin, paxillin, focal 
adhesion kinase (FAK), Integrin-Linked Kinase (ILK), PINCH, and parvins have been identified 
(Niederreiter, 1994; Zamir and Geiger, 2001).  The number of different proteins that are involved 
in the assembly of FAs, along with the interactions that they mediate, indicates a high level of 
molecular complexity (Niederreiter, 1994; Zamir and Geiger, 2001), which in turn underlines the 
importance of those proteins for cellular functions. 
 
The significance of such protein associations is particularly obvious in development. 
During normal embryonic development, cells are attached to or migrate on ECM, and in both 
cases they interact with several components of the matrix via integrins and other associated FA 
proteins.  These interactions are very dynamic and are continually modified until the 
developmental process has been successfully completed.  In fact, lack of certain components of 
FAs, as well as proteins that comprise the cell-cell junctions has been shown to hinder normal 
development and lead to embryonic lethality or other developmental defects.  Vinculin null mice, 
for example, are embryonic lethal with great defects in heart and brain development (Xu et al., 
1998), E-cadherin knockout embryos are unable to form trophectoderm epithelium(Larue et al., 
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1994), while ILK knockout mice die at the pre-implantation stage (Sakai et al., 2003).  This 
demonstrates the absolute requirement of certain interactions between cells and the ECM for the 
normal development, morphogenesis and life in general.  
1.1 THE PINCH-ILK-PARVIN COMPLEXES 
1.1.1 Molecular activities of ILK, PINCH and parvins 
One protein that is emerging as a key component of the FAs is Integrin-Linked Kinase (ILK).  
ILK was identified and cloned in 1996 based on its interaction with the β1-subunit of integrin 
(Hannigan et al., 1996b) and it was shown to localize to cell-ECM adhesions (Li et al., 1999a).  
It plays a crucial role in integrin-mediated cell adhesion and signaling (Brakebusch and Fassler, 
2003; Dedhar, 2000; Grashoff, 2004; Wu, 2001b; Wu, 2004c; Yoganathan et al., 2000).  ILK 
consists of three structurally distinct regions; four ANK repeats in the N-terminal region, 
followed by a pleckstrin homology (PH)-like domain and a C-terminal domain, which exhibits 
significant homology to Ser/Thr kinase catalytic domains (Grashoff, 2004; Hannigan et al., 
1996b; Wu and Dedhar, 2001a). ILK can phosphorylate several proteins including protein kinase 
B PKB/Akt (Delcommenne et al., 1998a), Gsk-3β  (Delcommenne et al., 1998a), and myosin 
light chain (Deng et al., 2001) and thereby regulates intracellular signaling (Hannigan et al., 
2005).  ILK also mediates multiple protein-protein interactions (Figure 1) (Mackinnon et al., 
2002b; Wu, 2001b; Wu and Dedhar, 2001a).  It binds to PINCH via its N-terminal ANK domain 
(Li et al., 1999a; Tu et al., 1999; Velyvis et al., 2001) and α- or β-parvin, members of the CH-
ILKBP/α-parvin/actopaxin/affixin protein family (Fukuda et al., 2003a; Fukuda et al., 2003b; 
Nikolopoulos, 2000; Tu et al., 2001a; Wu, 2001b; Wu and Dedhar, 2001a; Zhang et al., 2002a; 
Zhang et al., 2002b; Zhang et al., 2002), via its C-terminal domain, resulting in the formation of 
a ternary complex within cells.  PINCH consists of five LIM domains, each of which contains 
two Zn2+ fingers that mediate protein-protein interactions (Dawid et al., 1998; Jurata and Gill, 
1998; Schmeichel and Beckerle, 1994).  The N-terminal-most LIM1 domain mediates the 
interaction with ILK (Tu et al., 1999; Velyvis et al., 2001), whereas the C-terminal LIM domains 
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mediate interactions with several other proteins including Nck-2 (Tu et al., 1998; Velyvis et al., 
2003), thymosin β4 (Bock-Marquette et al., 2004), and RSU-1 (Kadrmas et al., 2004).  Parvins 
contain one N-terminal region and two C-terminal Calponin-Homology (CH) domains 
(Nikolopoulos and Turner, 2000; Olski et al., 2001; Tu et al., 2001; Yamaji et al., 2001).  In 
addition to ILK, other proteins including paxillin (Nikolopoulos and Turner, 2000), α-actinin 
(Yamaji et al., 2004) and actin (Nikolopoulos and Turner, 2000; Olski et al., 2001) have been 
shown to interact with α-parvin and/or β-parvin.  Thus, the PINCH-ILK-parvin complex likely 
functions as a molecular platform at cell-ECM adhesions mediating multiple interactions and 
hence regulates cell-ECM adhesion and signaling (Figure 1).  
 
 
 
Figure 1. Schematic representation of the protein-protein interactions mediated by ILK and 
proteins associated with it. In the schematic diagram of this figure, the stable PINCH-ILK-parvin 
complex is shown in blue and the alternative partners for ILK are enclosed in dashed boxes. All the 
reported bindings are shown with solid red arrows while other potential protein-protein interactions are 
shown with blue dashed arrows. RTKs:receptor tyrosine kinases. 
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PINCH, ILK and parvins are widely expressed in the human tissues and well-conserved 
among different species (Clark, 2003; Mackinnon et al., 2002b; Zervas and Brown, 2002; 
Zervas, 2001).  Genetic studies in Drosophila, C.elegans and mouse have demonstrated their 
essential roles for embryonic development and normal cell function in vivo (Zervas et al., 2001; 
Clark et al., 2003; Hobert et al., 1999; Mackinnon et al., 2002; (Lin et al., 2003).  For example, 
loss of ILK leads to peri-implantation lethality in the mouse (Brakebusch and Fassler, 2003), 
embryonic lethality in C.elegans (Mackinnon et al., 2002b) and Drosophila (Brakebusch and 
Fassler, 2003; Zervas, 2001), characterized by muscle detachment, and severe actin-related 
defects (Brakebusch and Fassler, 2003; Zervas, 2001).  Similarly, PINCH depletion seems to 
also lead to embryonic lethality during the phase of implantation (Grashoff, 2004). Interestingly 
enough, the interactions between PINCH, ILK and parvins are well conserved in C.elegans and 
Drosophila (Clark et al., 2003; Kadrmas et al., 2004; Lin et al., 2003; Mackinnon et al., 2002).  
They work together in a multi-protein complex in the invertebrate organisms as well.  Thus, the 
formation of the PINCH-ILK-parvin complex is likely crucial for the functions of these proteins.  
Indeed, the phenotypes resulting from loss of ILK or PINCH bear significant similarity to the 
ones observed when the complex formation is disrupted (Zhang et al., 2002). 
1.1.2 Assembly and regulation of the PINCH-ILK-parvin complexes 
Recent work has shown that ILK, PINCH and parvin are recruited to cell-ECM sites as a pre-
assembled complex (Zhang et al., 2002), indicating that the formation of the complex precedes 
the integrin-mediated cell adhesion and spreading.  The assembly of the PINCH-ILK-parvin 
complex is known to be regulated by two main signaling pathways, although other levels of 
regulation may be also involved. First, the complex formation is regulated by the protein kinase 
C (PKC) signaling pathway (Zhang et al., 2002). Inhibition of PKC leads to down-regulation of 
the assembled complex suggesting that the PINCH-ILK-parvin complex is an important 
downstream target of PKC pathway through which many cellular processes such as cell 
migration, spreading, and proliferation are regulated.  Second, the formation of the PINCH-ILK-
parvin complex is regulated by the phosphatidylinositol-3 (PI-3) kinase pathway, since inhibition 
of PI3K pathway by small compound inhibitors or by overexpressing PTEN also results in the 
inhibition of the complex assembly (Attwell et al., 2003). 
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 In mammalian cells, two structurally related PINCH proteins (termed as PINCH-1 and 
PINCH-2), which are encoded by two different genes, have been identified to date.  PINCH-1 
and PINCH-2 are co-expressed in a number of cell types and tissues (Braun et al., 2003; Wu, 
2004c; Zhang et al., 2002a).  Both PINCH-1 and PINCH-2 can bind to ILK (Zhang et al., 
2002a).  Furthermore, the binding of PINCH-1 and PINCH-2 to ILK is mutually exclusive 
(Zhang et al., 2002a).  As mentioned above, both α- and β-parvins are capable of binding to ILK 
(via their CH2 domain).  Thus, in many types of cells, there exist multiple PINCH-ILK-parvin 
complexes.  It is worth noting though, that the different PINCH-ILK-parvin complexes, although 
sharing certain common functions, they are not redundant or interchangeable but rather each one 
plays its own distinct role within the cell (Fukuda et al., 2003a). 
1.1.3 Signaling through the PINCH-ILK-parvin complexes 
Activation of ILK, either by integrin clustering, or by growth factors, affects multiple cell 
signaling pathways that regulate cell survival, proliferation and differentiation. As shown in 
Figure 2, ILK activation results in the phosphorylation and subsequent activation of PKB/Akt 
(Persad et al., 2000b; Troussard et al., 2003a; Wu and Dedhar, 2001a), as well as Extracellular 
signal-Regulated Kinase/Mitogen Activated Protein Kinase (Erk/MAPK) (Wu and Dedhar, 
2001a).  In addition, α-parvin, one of the partners of ILK in the PINCH-ILK-parvin ternary 
complexes, was shown to regulate cell survival signaling by affecting the membrane 
translocation of PKB/Akt (Fukuda et al., 2003b).  Thus, the components of the ILK complexes 
appear to function in concert to mediate cellular signaling.   
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Figure 2. Schematic representation of the signaling mediated by ILK. 
 
The activation of PKB/Akt, for instance, results in a cascade of signaling events leading 
to protection of cells from apoptosis (Downward, 2004; Franke et al., 2003; Hemmings, 1997).  
ILK can also phosphorylate and subsequently inhibit Glycogen Synthase Kinase 3-beta (GSK3-
β) in a PI3K-dependent manner (Delcommenne et al., 1998a; Mhashilkar et al., 2003; Tan et al., 
2001b; Wu and Dedhar, 2001a).  This leads to the induction of the transcriptional activities of 
AP-1 transcription factor as well as the β-catenin/Lymphoid Enhancer Factor-1(LEF1) 
transcription complex (Novak and Dedhar, 1999; Novak et al., 1998)(Figure 2). This in turn up-
regulates the expression of Matrix-metalloproteinase-9 (MMP-9) (Troussard, 2000), c-myc 
(Novak and Dedhar, 1999), and cyclin D1 respectively (D'Amico et al., 2000), resulting in 
degradation of the ECM, invasion and cell cycle progression.  Activation of PKB/Akt also leads 
to induction of the expression of hypoxia inducible factor 1α (HIF-1α), which in turn stimulates 
the expression of vascular endothelial growth factor (VEGF), and thus affecting angiogenesis 
(Figure 2) (Tan et al., 2004b).   
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Recent studies have identified several upstream regulators of ILK (Figure 2).  For 
example, ILK activity can be negatively regulated by PTEN (Persad et al., 2000b; Wu and 
Dedhar, 2001a) and ILK-associated phosphatase (ILK-AP)(Kumar et al., 2004) (Leung-
Hagesteijn et al., 2001).  Recently it was shown that β-parvin, one of its binding partners, is also 
capable of inhibiting it (Mongroo et al., 2004).  Taking into account the fact that α-parvin 
promotes cell survival through ILK signaling (Attwell et al., 2003; Fukuda et al., 2003b), it 
seems that α- and β-parvin, two binding partners of  ILK, exert antagonistic effects on ILK 
signaling.   In fact, the binding of α- and β-parvin to ILK is mutually exclusive (Zhang et al., 
2004).  Thus, ILK signaling, apart from PI3K and growth factors, is also regulated by its binding 
partners. 
 
Consistent with the fact that ILK regulates major signaling pathways, it has been 
implicated in many physiologic or pathological processes such as cell differentiation, 
proliferation, migration, platelet aggregation, and angiogenesis (Friedrich et al., 2004b; 
Huang, 2000; Kaneko et al., 2004; Tan et al., 2004b; Terpstra, 2003; Wu et al., 1998; Yamaji, 
2002).  ILK was shown to be an important regulator of myogenic differentiation, affecting the 
initial stages of this process by regulating MAPK activation (Huang, 2000).  In addition to 
myogenic differentiation, ILK was shown to be involved in chondrocyte proliferation and 
differentiation (Terpstra, 2003) and platelet aggregation (Yamaji, 2002).  Furthermore, it was 
shown to regulate tumor angiogenesis (Tan et al., 2004b) by stimulating the expression of 
VEGF.  In that case, inhibition of ILK leads to the inhibition of VEGF-mediated endothelial cell 
migration and angiogenesis (Tan et al., 2004b). Finally, recent work by Friedrich et.al., done in 
mice using the Cre-Lox system and in the developing zebra fish using the antisense technology, 
has shown that ILK plays a fundamental role in vascular development and endothelial cell 
survival in vertebrates (Friedrich et al., 2004b).   
 
There is compelling evidence suggesting that ILK plays a role in oncogenic 
transformation.  First, overexpression of ILK promotes anchorage-independent growth, and cell 
cycle progression (Hannigan et al., 1996; Radeva et al., 1997(White et al., 2001; Wu et al., 
1998).  Second, ILK overexpression in epithelial cells leads to down-regulation of E-cadherin 
and disruption of cell-cell adhesions (Hannigan et al., 1996b; Wu et al., 1998), as well as 
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inhibition of suspension-induced apoptosis (anoikis), all of which are important traits of cancer 
cells (Avizienyte, 2002; Cairns, 2003; Cavallaro, 2001; Conacci-Sorrell, 2002; Hajra, 2002; 
Hanahan, 2000; Popov, 2000). Third, modest overexpression of ILK in intestinal and mammary 
epithelial cells promotes invasion, and is accompanied by translocation of β-catenin to the 
nucleus, complex formation between β-catenin and the LEF1 transcription factor and subsequent 
transcriptional activation of pro-survival genes such as MMP-9, cyclins, and cMYC (Ben-Ze'ev, 
1999; Novak and Dedhar, 1999; Novak et al., 1998).  Finally, clinic studies have shown that ILK 
expression level increases in a number of malignancies and there is often a correlation between 
ILK expression levels and the tumor grade. For instance, the ILK level is increased in highest 
grade prostate adenocarcinoma as compared to lower grade or to benign prostate hyperplasia 
(Graff, 2001; Yoganathan et al., 2002b).   It is also correlated with the ovarian tumor grade 
(Ahmed, 2003) and melanoma progression and poor prognosis (Dai et al., 2003).  Both ILK 
activity and expression level are also increased in polyps from Familial Adenomatous Polyposis 
patients (Marotta et al., 2003; Marotta et al., 2001). This combined with all the above-described 
evidence indicates that ILK may comprise a useful biological marker for certain types of cancer 
(Ahmed, 2004) or even a potent target for anti-cancer therapy (Attwell et al., 2000b; Mhashilkar 
et al., 2003; Yoganathan et al., 2000) (Hannigan et al., 2005).  
1.1.4 Proteins interacting with the PINCH-ILK-parvin complexes 
The interactions of ILK with PINCH and α-parvin are necessary but not sufficient for ILK 
localization to cell-ECM adhesion sites (Zhang et al., 2002).  This suggests that there are other 
proteins that interact with the components of the PINCH-ILK-parvin complex and mediate its 
localization to cell-ECM sites.  Indeed, each of the proteins forming the ternary complex of 
PINCH-ILK-parvin interacts with multiple proteins within the cell.  For example, ILK can 
interact with β1 and β3 integrin cytoplasmic domains (Hannigan et al., 1996b), paxillin 
(Nikolopoulos, 2001), ILK-AP (Kumar et al., 2004) and Mitogen inducible gene-2 (Mig-2), a 
mammalian homologue of C.elegans UNC-112 (Tu et al., 2003a).  Studies in C.elegans have 
shown that UNC-112 binds to PAT4/ILK and is essential for the recruitment of PAT4/ILK to 
attachment sites (Mackinnon et al., 2002b), thus making UNC-112 a possible candidate for 
recruiting ILK to cell-ECM sites.  Mammalian Mig-2 also interacts with ILK.  In addition, it 
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interacts with migfilin, a recently identified LIM domain-containing protein (Tu et al., 2003a).  
Migfilin, in turn, binds to filamin A and C (hence the name migfilin) (Tu et al., 2003a).  These 
interactions are important for actin cytoskeleton organization and processes that require 
extensive shape modulation such as cell migration (Stossel and Hartwig, 2003; Tu et al., 2003a).  
 
Migfilin consists of five distinct domains; an N-terminal domain, a proline-rich domain 
in the center, and three LIM domains in the C-terminal region.  Three splice variants of migfilin 
have been identified to date; the long form migfilin with all the above-described domains, a short 
form lacking the proline-rich domain (Tu et al., 2003a), and FBLP-1, which lacks the last LIM 
domain (Takafuta, 2003). The C-terminal region of migfilin is responsible for the binding to 
Mig-2, the N-terminal accounts for the interaction with filamin (Tu et al., 2003a), while the 
central proline-rich domain mediates the interaction with VASP (Y. Zhang and C. Wu, 
manuscript submitted), another actin-regulatory protein (Krause et al., 2002; Krause et al., 2003).  
Interestingly, Cal, the mouse homologue of migfilin, is capable of interacting with the cardiac 
homeobox transcription factor CSX/Nkx2-5 via the C-terminal LIM domains (Akazawa, 2004).  
Taking into consideration the fact that the LIM domain motif with the tandem zinc fingers is 
known to mediate multiple protein-protein interactions (Jurata and Gill, 1998; Schmeichel and 
Beckerle, 1994(Bach, 2000; Dawid, 1998; Khurana, 2002), it is anticipated that other binding 
partners of migfilin exist as well. 
 
In a wide variety of fibroblasts, epithelial and endothelial cells, migfilin is present at the 
cell-ECM adhesion sites where it is being recruited by Mig-2, and it is also associated with actin 
filaments as a result of its interaction with filamin (Tu et al., 2003a). Consistent with its 
association with the CSX/Nkx2-5 transcription factor, the mouse homologue of migfilin was also 
detected in the nucleus (Akazawa, 2004).  The nuclear trafficking of migfilin has not been 
studied extensively, but existing evidence indicates that migfilin enters the nucleus in response to 
high intracellular calcium levels, since treatment of the cells with a calcium ionophore promotes 
the nuclear accumulation of the protein (Akazawa, 2004).  As for the nuclear export of migfilin, 
the nuclear export signal (NES) within the proline-rich domain, was shown to be responsible 
(Akazawa, 2004).   
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Studies in C.elegans reveal that UNC-112, the invertebrate homologue of Mig2, is 
essential for the localization of integrins in the muscle cell membrane, indicating that Mig-2 
itself is important for integrin-related cell functions (Rogalski, 2000).  Depletion of Mig2 from 
mammalian cells impairs cell spreading showing that Mig-2 is important for cell shape 
modulation (Tu et al., 2003a).  Migfilin, the binding partner of Mig-2, is also critical for cell 
shape modulation. Depletion of migfilin impairs cell spreading and reduces the level of 
filamentous actin (F-actin) as compared to the level of free G-actin, thus playing an important 
role in actin remodeling (Tu et al., 2003a).  Intriguingly, a recent study demonstrated that Mig-2 
was transcriptionally elevated in uterine leiomyomas as compared to normal myometrium (Kato, 
2004). This suggests a putative role for Mig-2 in the hormone-mediated growth of benign 
smooth muscle tumor cells of uterine leiomyomas.  
 
New insight into the functional role of migfilin in cells is gained from a recent study 
where Cal, the mouse homologue of migfilin, is shown to be important for cardiac differentiation 
(Akazawa, 2004). Interestingly, this study shows that the mouse homologue of migfilin 
possesses itself a transcription-promoting activity and by association with the CSX/Nkx2-5 
transcription factor it is capable of transactivating certain genes such as the atrial natriuretic 
peptide (ANP) promoter, and the transcription factor GATA-4 (Akazawa, 2004).  Thus, migfilin 
seems to play a very significant part in the regulation of transcription of cardiac genes and 
cardiac development in general.  
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2.0  PHYSICAL AND FUNCTIONAL ASSOCIATION OF MIGFILIN WITH CELL-
CELL ADHESIONS 
2.1 INTRODUCTION 
As mentioned above, cell-cell and cell-extracellular matrix (ECM) adhesions are 
constituently and functionally distinct subcellular structures that are essential for the assembly of 
cells into tissues, and for communication between neighboring cells and between cells and the 
ECM. Identification of the molecular constituents of cell-cell and cell-ECM adhesions and the 
structural determinants that control their localization to these two distinct subcellular adhesion 
structures are therefore of fundamental importance. Migfilin is a recently identified and cloned 
protein that is a component of cell-ECM adhesions, where it links the cell-ECM adhesions to the 
actin cytoskeleton and functions in actin cytoskeleton remodeling and cell shape modulation (Tu 
et al., 2003).  
 
In the present study, we show that migfilin not only localizes to cell-ECM adhesions but 
also is recruited to cell-cell junctions in epithelial and endothelial cells. Using a combination of 
biochemical, cell biological, immunofluorescence and immunoelectron microscopic approaches, 
we have characterized the ultrastructure of the migfilin-containing structures at cell-cell 
junctions. In addition, we have identified the determinants that control migfilin localization to 
cell-cell and cell-ECM adhesions. Finally, we have investigated the function of migfilin in cell-
cell junctions by RNA interference.  
 
Our results identify a new component of adherens junctions and suggest an important role 
of migfilin in the organization of the cell-cell adhesion structure. 
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2.2  MATERIALS AND METHODS 
Cell lines and antibodies 
Primary newborn human embryonic keratinocytes (NHEK) (Clonetics) were cultured in KBM-2 
medium containing the supplements recommended by the company.  Primary human 
microvascular endothelial cells (HMVEC) were purchased from Clonetics and cultured in EGM-
MV medium (Clonetics).  HaCat and MCF-7 cells were cultured in DMEM medium containing 
10% Fetal Bovine Serum (FBS), 1% Glutamax, and 1% penicillin/streptomycin. Human 
fibrosarcoma HT-1080 cells were cultured in Eagle's MEM medium supplemented with L-
glutamine, 10% FBS, and non-essential amino acids.  Mouse monoclonal antibodies recognizing 
migfilin and Mig-2 were generated as described previously (Tu et al., 2003).  Rabbit polyclonal 
antibodies against β-catenin and α-catenin were purchased from Sigma.  Mouse monoclonal 
anti-E-cadherin antibody (SHE78-7) was from Calbiochem.  Rhodamine RedTM-conjugated anti–
mouse IgG antibody, Rhodamine RedTM-conjugated anti-rabbit IgG antibody, and FITC-
conjugated anti-mouse IgG antibody were purchased from Jackson ImmunoResearch 
Laboratories. For the immunofluorescent staining in Figure 3, a goat anti-mouse Alexa 488 
antibody from Molecular Probes, Eugene OR, and a goat anti-rabbit Cy3 from Jackson 
Immunolabs were used as secondary antibodies.  
 
Migfilin expression vectors, site-directed mutagenesis and DNA transfection 
The expression vectors encoding GFP-tagged migfilin, the short form splicing variant of migfilin 
that lacks the proline-rich domain (migfilin(s)), and the deletion mutants of migfilin (as specified 
in each experiment) were generated by inserting the corresponding cDNA fragments into 
pEGFP-C2 vector (Clontech).  Point mutations were generated by PCR using the Pfu DNA 
polymerase from Invitrogen, and the QuickChangeTM site-directed mutagenesis system from 
Stratagene.  All mutations were confirmed by DNA sequencing.  HaCat cells were transfected 
with expression vectors encoding GFP-tagged wild type and mutant forms of migfilin with 
LipofectAmine PLUS (Life Technologies) following the manufacturer’s protocol. 
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Immunofluorescent staining and Confocal microscopy 
Immunofluorescent staining was performed as described (Tu et al., 2003; Zhang et al., 2002). 
Briefly, cells were plated on fibronectin-coated cover slips, fixed with 4% paraformaldehyde, 
and incubated at room temperature with appropriate primary and secondary antibodies or 
Rhodamine-conjugated phalloidin as specified in each experiment.  In experiments in which cells 
were transfected with GFP-migfilin expression vectors, Rhodamine RedTM-conjugated secondary 
anti–mouse or anti-rabbit IgG antibodies were used.  In double staining experiments with mouse 
anti-migfilin antibody and rabbit anti-β-catenin antibody, FITC-conjugated anti-mouse IgG and 
Rhodamine RedTM-conjugated anti-rabbit IgG secondary antibodies were used.  The cells were 
observed either under a Leica DM R fluorescence microscope or an Olympus Fluoview BX61 
confocal microscope. 
 
Cytoskeletal Extraction 
Cytoskeletal extractions of cells were performed essentially as described previously (Heuser and 
Kirschner, 1980).  Briefly, with all solutions at 37oC, cells on 12 mm round glass coverslips, 
were washed with Cytoskeletal Buffer (100 mM PIPES, pH 6.9, 0.1 mM EDTA, 0.5mM MgCl2, 
4 M glycerol, 1:100 dilution mammalian protease inhibitor cocktail, Sigma), and then extracted 
with Cytoskeletal Buffer supplemented with 0.75% Triton X-100 for 3 minutes with one change 
of the extraction buffer during this time period.  Extracted cells were washed once with 
Cytoskeletal Buffer, and then fixed in Cytokeletal Buffer supplemented with 2% 
paraformaldehyde for 1 hour.  Cells were stored in PBS at 4oC until use. 
 
Cationic Colloidal Silica Unroofing of Cells* 
Cells were unroofed as described previously (Stolz and Jacobson, 1992). All isolation solutions 
were maintained at 4oC. Briefly, cells were washed in MES-Buffered Saline (MBS: 20 mM 
morpholinoethane sulfonic acid, 135 mM NaCl, 0.5 mM CaCl2, 1 mM MgCl2), and were then 
overcoated with a 1% solution of cationic colliodal silica, which was prepared as a 30% stock 
colloid as described (Chaney and Jacobson, 1983).  Cells were subsequently washed with MBS, 
overcoated with 1% polyacrylic acid in MBS (stock 25% aqueous polyacrylic acid solution, ave. 
mol. wt. 100,000, Aldrich, St. Louis, MO).  Then, cells were washed with MBS and they were 
allowed to swell in hypotonic lysis buffer for 10 min [lysis buffer: 2.5mM imidizole, pH 7.0, 
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supplemented with protease inhibitors (1:100 dilution mammalian protease inhibitor cocktail, 
Sigma)].  Cells were then unroofed by squirting the monolayers with lysis buffer through a 5 ml 
syringe fitted with a blunted, flattened 18 gauge needle.  The degree of lysis was monitored by 
observing cells on an inverted microscope.  Footprints were washed once with MBS and fixed in 
2% paraformaldehyde in PBS for 1 hr and stored in PBS at 4oC until use.  (*Cationic colloidal 
silica can be obtained by written request from Dr. Donna Beer Stolz, University of Pittsburgh, 
Pittsburgh, PA 15261, E-mail: dstolz@pitt.edu.) 
 
Immunoelectron microscopy 
HaCat cells were fixed in cryofix (2% paraformaldehyde, 0.01% glutaraldehyde in 0.1 M PBS) 
and stored at 4°C for 1 hour. Cells were pelleted and resuspended in a small amount of 3% 
gelatin in PBS, solidified at 4°C then fixed for an additional 15 minutes in cryofix. Gelatin-cell 
block was cryoprotected in PVP cryoprotectant overnight at 4°C [25% poly(vinylpyrrolidone), 
2.3 M sucrose, 0.055 M Na2CO3, pH 7.4 (Tokuyasu, 1989)]. Cell blocks were frozen on 
ultracryotome stubs under liquid nitrogen and stored in liquid nitrogen until use. Ultrathin 
sections (70-100 nm) were cut using a Reichert Ultracut U ultramicrotome with a FC4S cryo-
attachment, lifted on a small drop of 2.3 M sucrose and mounted on Formvar-coated copper 
grids. Sections were washed three times with PBS, then three times with PBS containing 0.5% 
bovine serum albumin and 0.15% glycine (PBG buffer); this was followed by a 30 minute 
blocking incubation with 5% normal goat serum in PBG. Sections were labeled with a rabbit 
anti-â-catenin antiserum (1:100) and the ascites fluid of the mouse monoclonal anti-migfilin 
antibody (clone 43) (1:100) in PBG for 1 hour. Sections were washed four times in PBG and 
labeled with goat anti-rabbit (10 nm) or goat anti-mouse (5 nm) gold conjugated secondary 
antibodies (Amersham), each at a dilution of 1:25 for 1 hour. Sections were washed three times 
in PBG, three times in PBS then fixed in 2.5% glutaraldehyde in PBS for 5 minutes, washed 
twice in PBS then washed six times in ddH2O. Sections were post-stained in 2% neutral uranyl 
acetate for 7 minutes, washed three times in ddH2O, stained for 2 minutes in 4% uranyl acetate 
then embedded in 1.25% methyl cellulose. Labeling was observed on a JEOL JEM 1210 electron 
microscope (Peabody, MA) at 80 kV. 
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 Pre-embedding immuno-transmission microscopy 
HaCat cells were grown on 35 mm tissue culture plates, the cytoskeleton was extracted as 
described above and cells were fixed with 2% paraformaldehyde in PBS for 1 hr.  Cells were 
then washed 3 times with PBS, and 3 times with PBS supplemented with 0.5% BSA and 0.15% 
glycine (PBG).  Following this washing step, cells were blocked in 20% normal goat serum in 
PBG for 40 min and were then washed once with PBG.  Primary antibodies were added to cells 
in PBG at designated dilutions and incubated at room temperature for 4 hr.  Cells were washed 4 
times in PBG and secondary antibodies conjugated to gold (goat anti-rabbit, 5 nm, goat anti-
mouse, 10 nm, Amersham) were added to the cells overnight at 4oC.  Cells were then washed 3 
times in PBG, and 3 times in PBS and they were fixed in 2.5% glutaraldehyde for 1 hr.  Another 
wash step in PBS followed and cells were then post-fixed in 1% aqueous osmium tetroxide for 1 
hr. They were subsequently washed in PBS and were dehydrated through a 30-100% ethanol 
series and several changes of Polybed 812 embedding resin (Polysciences, Warrington, PA).  
Cultures were embedded in by inverting Polybed 812-filled BEEM capsules on top of the cells.  
Blocks were cured overnight at 37oC, and then cured for two additional days at 65oC.  
Monolayers were pulled off the tissue culture plates. Ultrathin en face sections (60 nm) of the 
cells were obtained on a Riechart Ultracut E microtome, post-stained in 4% uranyl acetate for 
10min and 1% lead citrate for 7 min. Sections were finally viewed on a JEOL JEM 1210 
transmission electron microscope (JEOL, Peobody MA) at 80 KV. 
 
Calcium chelation assays 
The calcium chelation assay was essentially performed as described previously (Helwani et al., 
2004; Rothen-Rutishauser et al., 2002). Briefly, MCF-7 cells were plated on fibronectin-coated 
coverslips, they were allowed to attach, and were then subject to serum starvation for 18 hours.  
The medium was then switched to DMEM supplemented with 4 mM EGTA and 1mM MgCl2 
and the cells were incubated at 37oC for 30 minutes.  Cells were then washed twice with PBS 
and the medium was changed back to the regular calcium-containing culture medium.  After 
incubation for periods of time as specified, cells were fixed and dually stained with mouse anti-
migfilin antibody and rabbit anti-β-catenin antibody.  
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 In some experiments, MCF7 mammary epithelial cells were transiently transfected with 
an expression vector encoding GFP-migfilin using LipofectaminePLUS.  Twenty four hours 
following the transfection, cells were plated on fibronectin-coated coverslips and were then 
subject to serum starvation for 18 hours.  The medium was then changed to DMEM 
supplemented with 4 mM EGTA, 1mM MgCl2 and a function-blocking mouse monoclonal anti 
E-cadherin antibody (SHE78-7, 4 µg/ml) or an irrelevant mouse IgG (4 µg/ml) as a control.  The 
cells were incubated at 37oC for 1 hour and then washed twice with PBS and the medium was 
switched back to the normal culture medium, which again contained 4 µg/ml of either the 
function-blocking anti-E-cadherin antibody or the irrelevant control mouse IgG antibody.  One 
hour following the switch to the normal calcium-containing medium, cells were fixed with 4% 
paraformaldehyde and stained with a rabbit polyclonal anti-β-catenin antibody and a Rhodamine 
RedTM-conjugated anti-rabbit IgG antibody. 
 
RNA interference 
Human fibrosarcoma HT-1080 cells were transfected with a siRNA that specifically targets 
migfilin mRNA (sense sequence: 5'-AAAGGGGCAUCCACAGACAUC-3'), or a 21-nucleotide 
irrelevant RNA as a control, as previously described (Tu et al., 2003).  The cells were analyzed 
by Western blotting and immunofluorescent staining two days after the siRNA transfection. 
 
Cell dissociation assay 
Cell dissociation assay was performed following a previously published method (Takeda et al., 
1995). Briefly, the cells as specified in each experiment) were detached from culture plates with 
a rubber policeman and passed through glass Pasteur pipettes ten times. The cells were then fixed 
in 1% glutaraldehyde and pictures were taken under an Olympus IX70 inverted microscope 
equipped with a MagnaFireTM digital camera. The extent of cell dissociation was represented by 
the ratio of the number of particles (Np) over the number of cells (Nc) (Np/Nt). The values of 
Np/Nc were calculated by analyzing at least 500 cells from each sample. 
 17 
2.3 RESULTS 
Migfilin is a component of cell-cell junctions in epithelial and endothelial cells  
Epithelial cells are attached not only to ECM but also to neighboring cells via highly specialized 
subcellular structures termed cell-cell junctions. To analyze the subcellular localization of 
migfilin in epithelial cells, we immunofluorescently stained human primary keratinocytes with a 
monoclonal antibody that specifically recognizes migfilin (Tu et al., 2003). Clusters of migfilin 
(Fig. 3A, arrows) were detected at cell-cell junctions where abundant β-catenin (Fig. 3B) and E-
cadherin (not shown), which are welldescribed components of cell-cell junctions, were present. 
As expected, migfilin clusters were also detected at cell-ECM adhesions (Fig. 3A, arrowheads) 
lacking β-catenin (Fig. 3B) and E-cadherin (not shown). Colocalization of migfilin with β-
catenin and E-cadherin at cell-cell adhesions was also observed in immortalized HaCat 
keratinocytes (not shown).  
 
Figure 3. Migfilin localizes to cell-
cell junctions in epithelial and endothelial 
cells. (A-D) Primary newborn human 
embryonic keratinocytes (A and B), 
immortalized human keratinocytes (HaCat) 
(C and D) and primary human microvascular 
endothelial cells (E and F) were double 
stained with a mouse monoclonal anti-
migfilin antibody (clone 43) (A, C and E) 
and a rabbit polyclonal anti-β-catenin 
antibody (B and F) or anti-FAK antibody 
(D). The images were recorded using a 
Leica DM R fluorescence microscope 
equipped with a Hamamatsu ORCA-ER 
digital camera. The cell-cell and cell-ECM 
adhesions are indicated by arrows and 
arrowheads, respectively. Note that a 
fraction of migfilin was co-clustered with β-
catenin at cell-cell junctions (arrows, C) that 
lack FAK (D). Migfilin was also detected at 
FAK-rich cell-ECM adhesions (arrowheads, 
C and D). Bars in A, C and E, 8 µm. 
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Double staining of the human keratinocytes with the mouse monoclonal anti-migfilin 
antibody and a rabbit polyclonal anti-FAK antibody confirmed that migfilin was clustered at 
both cell-ECM adhesions (Fig. 3C, arrowheads) where FAK was concentrated (Fig. 3D) and cell-
cell adhesions (Fig. 3C, arrows) that lacked FAK (Fig. 3D). The localization of migfilin to both 
cell-cell and cell-ECM adhesions has also been observed in other epithelial cells that have been 
analyzed, including human mammary epithelial cells and Madin-Darby canine kidney epithelial 
cell (not shown). To test whether migfilin localizes to cell-cell junctions in endothelial cells, 
another major type of cells that assemble both cell-cell and cell-ECM junctions, we stained 
primary human microvascular endothelial cells with the monoclonal antimigfilin antibody. As in 
epithelial cells, migfilin was clustered at both cell-cell junctions (Fig. 3E, arrows), where 
abundant β-catenin was detected (Fig. 3F), and cell-ECM adhesions (Fig.3E, arrowheads) that 
lacked β-catenin (Fig. 3F).   
 
 
 
Figure 4. Immunofluorescent confocal microscopic analysis of cell-cell adhesion localization of 
migfilin. Human immortalized keratinocytes (HaCat cells) were double stained with monoclonal anti-
migfilin antibody (clone 43) (A and D) and a rabbit polyclonal anti- β-catenin antibody (B and E) 
observed under an Olympus Fluoview BX61 confocal microscope. The x-z sections at the lateral (A and 
B) and basal (D and E) levels were shown. (C, F) Images merged from the migfilin (green) and β-catenin 
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(red) staining at the lateral and basal levels, respectively. The arrow in C indicates the position of the xz 
cross section (G). Bar, 8 µm. 
 
To confirm that migfilin colocalizes with β-catenin at cell-cell adhesions, we analyzed 
human keratinocytes by confocal immunofluorescence microscopy. The results showed that 
migfilin was co-clustered with β-catenin at lateral cell-cell junctions (Fig. 4A-C,G). Clusters of 
migfilin were also detected at basal cell-ECM adhesions where β-catenin was not concentrated 
(Fig. 4D-G). 
 
Migfilin forms detergent-resistant clusters that associate with actin bundles at cell-cell 
junctions 
We next sought to characterize the association of migfilin with cell-cell junctions. We 
first tested whether migfilin could be removed from cell-cell junctions by extraction with 
nonionic detergents.   To do this, we extracted HaCat cells with a Triton X-100-containing 
buffer. Analyses of the Triton X-100-extracted cells showed that migfilin remained to associate 
with β-catenin at cell-cell adhesions (Fig. 5A-C, arrowheads).  Furthermore, double staining of 
the cells with anti-migfilin monoclonal antibody and phalloidin showed that migfilin was co-
clustered with the anchoring sites of filamentous actin at cell-cell junctions, forming discrete 
structures that appeared to bridge neighboring cells (Fig. 5D).  
 
It is well known that in epithelial cells, filamentous actin forms a network (Fig. 5G) 
linking the basal ECM adhesions with lateral cell-cell junctions, and the latter supports the 
connections between neighboring cells and the formation of epithelial sheets. To confirm that the 
migfilin clusters are physically associated with these two (basal cell-ECM adhesions and lateral 
cell-cell adhesions) adhesion structures, we physically separated cell-cell and cell-ECM 
adhesions using a cationic colloidal silica ‘unroofing’ protocol (Stolz and Jacobson, 1992). 
Staining of the ‘unroofed’ cells showed that migfilin clusters at cell-cell-junctions were removed 
with the apical and lateral plasma membrane and the actin bundles that were anchored, whereas 
migfilin clusters at the basal ECM adhesions (or ‘cell footprints’) and the associated filamentous 
actin remained (Fig. 5E,I). Additionally, the association of migfilin with the basal ECM 
adhesions, like that of migfilin with cell-cell junctions, resisted nonionic detergent extraction 
(Fig. 5F). 
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Figure 5.Detergent-resistant association of migfilin with filamentous actin at cell-cell junctions. (A-
C) HaCat cells were subject to cytoskeletal extraction as described in Materials and Methods. The cells 
were then double stained with the mouse anti-migfilin (green, A) and rabbit anti-β-catenin (red, C) 
antibodies (arrowheads). The images were merged and are shown in B. (D-F) HaCat cells were Triton X-
100-extracted (D), unroofed (E), or extracted and unroofed (F) as described in Materials and Methods. 
The cells were then costained with the monoclonal anti-migfilin antibody, which was detected with an 
Alexa 488-conjugated antimouse IgG antibody (green), Rhodamine-conjugated phalloidin (red) and 
Hoechst dye 33258 (blue). Bars, 25 µm. (G-I) Schematic representation of the Triton X-100-extracted 
and/or the cationic colloidal silica unroofed cells. 
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Immunoelectron microscopic analyses of migfilin clusters at cell-cell junctions 
To define the localization and ultrastructure of migfilin at cell-cell junctions at higher 
magnification, we analyzed the cells by immunoelectron microscopy. Consistent with the 
immunofluorescent confocal microscopic results (Fig. 4), immunoelectron microscopic analysis 
of unextracted HaCat cells showed that migfilin is localized in the vicinity of β-catenin at cell-
cell contacts (Fig. 6A).   
 
To visualize filamentous actin and further test whether migfilin is closely associated with 
filamentous actin and β-catenin, we extracted the cells with a Triton X-100-containing buffer and 
analyzed them by pre-embedding immunotransmission microscopy as described in Materials and 
Methods.  
 
The results showed that, consistent with the immunofluorescent microscopic analyses 
(Fig. 5), migfilin associated with actin bundles that linked neighboring cells (Fig. 6B, arrows). 
The migfilin clusters (Fig. 6C, arrowheads) were not associated with desmosomes (Fig. 6C, 
arrows).  
 
Furthermore, double staining of cells with anti-migfilin and anti-β-catenin antibodies 
showed that migfilin was closely associated with β-catenin (often within 100 nm), and they 
formed electron dense, compact complexes that appeared to clamp actin bundles (Fig. 6D). 
These results suggest that migfilin forms a complex with both β-catenin and filamentous actin at 
adherens junctions.  
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 Figure 6. Immunoelectron microscopic analyses of 
migfilin clusters at cell-cell junctions. 
Immunoelectron microscopic analysis of HaCat cells 
was performed as described in Materials and Methods. 
Cell adhesions connecting the two cells are shown in 
the orientation between the two open arrows. Note that 
the anti-β-catenin antibody (10 nm gold) and the anti-
migfilin antibody (5 nm gold) were colocalized at areas 
of cell-cell contacts (between arrowheads). (B, C) 
Single pre-embedding immunotransmission 
microscopic images of HaCat cells at low (B) and high 
(C) magnification. In B, migfilin (beads) was clustered 
and associated with the actin bundles at cell-cell 
junctions (arrows). N indicates the nuclei of two 
neighboring cells. In C, desmosomes are indicated by 
arrows, and migfilin clusters are shown by arrowheads. 
Note that migfilin clusters were associated with the 
actin bundles but not desmosomes. (D) HaCat cells 
were prepared for pre-embedding immunotransmission 
microscopy and double stained with anti-migfilin and 
anti-β-catenin antibodies. Note that migfilin (10 nm 
gold particles) and β-catenin (5 nm gold particles) were 
closely clustered with the actin bundles. 
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The recruitment of migfilin to cell-cell junctions is temporally separable from that of β- 
catenin  
To analyze the temporal relation between migfilin and β-catenin recruitment to adherens 
junctions, we disassembled the adherens junctions by treating epithelial cells with a calcium-
chelator (EGTA), and then added back medium that contains calcium, which is known to induce 
E-cadherinmediated adherens junction assembly (Nagafuchi et al., 1987). The epithelial cells 
were fixed at different time points after switching to calcium-containing medium. 
 
 
Figure 7. Calcium-induced 
migfilin localization to adherens 
junction. (A-D) MCF7 mammary 
epithelial cells were subject to 
calcium-chelation assay as described 
in Materials and Methods. The cells 
were fixed at 15 minutes (A and B) 
and 30 minutes (C and D) after 
switching to calcium-containing 
medium, and double stained with a 
rabbit anti-β-catenin antibody (A 
and C) and the mouse monoclonal 
anti-migfilin antibody (B and D). 
(E,F) MCF7 mammary epithelial 
cells were transiently transfected 
with an expression vector encoding 
GFP-migfilin. The cells were subject 
to calcium-chelation assay in the 
presence of a function-blocking 
mouse monoclonal anti-E-cadherin 
antibody (SHE78-7) (G-J) or a non-
specific mouse IgG as a control (E 
and F) as described in Materials and 
Methods. The cells were fixed at 60 
minutes after switching to calcium-
containing medium, and stained with 
a rabbit anti-β-catenin antibody (E, 
G and I) and a Rhodamine RedTM-
conjugated anti-rabbit IgG antibody. 
β-Catenin (E, G and I) and 
GFPmigfilin (F, H and J) at the cell-
cell (E-H) or cell-ECM (I and J) 
adhesions were detected using a 
Leica DM R fluorescence 
microscope. Bars, 5 µm. 
 24 
Immunofluorescence staining analysis with anti-migfilin and anti-β-catenin antibodies 
showed that β-catenin was clustered at adherens junctions within 15 minutes from the calcium 
switch (Fig. 7A), whereas at the same time point migfilin was not clustered at adherens junctions 
(Fig. 7B). Soon after the clustering of β-catenin (30 minutes from the calcium-switch), however, 
migfilin (Fig. 7D) was recruited to the adherens junctions where β-catenin (Fig. 7C) clusters 
were detected. Thus, the recruitment of migfilin to the adherens junctions appears to be 
temporally separable from that of β-catenin, which has been shown to be co-recruited with E-
cadherin from ER to adherens junctions (Chen et al., 1999). 
 
The recruitment of migfilin to cell-cell junctions depends on cadherin-mediated cell-cell 
adhesion 
To test whether the localization of migfilin to cell-cell junctions depends on cadherin, we 
treated MCF-7 cells with a function-blocking mouse monoclonal anti-E-cadherin antibody 
(SHE78-7). Because the presence of the mouse monoclonal anti-E-cadherin antibody obscures 
the immunofluorescent detection of migfilin using the mouse anti-migfilin antibody, we 
transfected MCF-7 cells with an expression vector encoding GFP-migfilin and analyzed the 
effect of the function-blocking anti-E-cadherin antibody on the localization of GFP-migfilin.  
 
Consistent with the results obtained with the monoclonal anti-migfilin antibody (Fig. 
7C,D), GFP-migfilin was readily recruited to β-catenin-rich cell-cell adhesions in MCF-7 cells 
that were incubated with the control mouse IgG (Fig. 7E, F). By marked contrast, in MCF-7 cells 
that were incubated with the function-blocking anti-E-cadherin antibody, no GFP-migfilin 
clusters were detected at the cell-cell boundaries (Fig. 7G, H). The presence of the function-
blocking anti-E-cadherin antibody, however, did not prevent the recruitment of GFP-migfilin to 
cell-ECM adhesions (Fig. 7I, J). Thus, the recruitment of migfilin to cell-cell junctions, but not 
that of migfilin to cell-ECM adhesions, depends on cadherin mediated cell-cell adhesion. 
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Figure 8. Expression 
and schematic 
representation of the 
wild-type and mutant 
forms of migfilin and 
their localization to 
cell-cell and cell-ECM 
adhesions. (A) 
Expression of GFP-
tagged wildtype and 
mutant forms of 
migfilin. HaCat cells 
were transfected with 
expression vectors 
encoding the wild-type 
and mutant forms of 
migfilin as indicated in 
the figure. The cell 
lysates (15 µg/lane) 
were analyzed by 
western blotting with an 
anti- GFP antibody. N-
ter, residues 1-85; PR-
LIM1-3, residues 85-
373; LIM1-3, residues 
176-373; LIM1N, 
residues 205-373; 
C243, C291 and C306, 
migfilin bearing 
C243G, C291G or 
C306G point mutation. 
C306(s), migfilin(s) 
bearing the C306G 
point mutation. (B) 
Summary of the 
localization of the wild-
type and mutant forms 
of migfilin to cell-cell 
and cell-ECM 
adhesions, based on the 
results presented in this 
paper. 
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The C-terminal LIM domains, but not the N-terminal filamin-binding domain, mediate 
migfilin localization to cell-cell junctions.  
In addition to the central proline-rich domain, migfilin contains an N-terminal filamin-
binding domain and a Mig-2-binding C-terminal region that consists of three LIM domains.  To 
determine which of the migfilin regions mediates migfilin localization to adherens junctions, we 
generated expression vectors encoding GFP-tagged migfilin N-terminal domain (GFP-N-Ter), 
the proline-rich and the C-terminal LIM domains (GFP-PR-LIM1-3) and the C-terminal LIM 
domains (GFP-LIM1-3), respectively (Fig. 8B).  HaCat cells were transfected with the GFP 
expression vectors encoding the different domains of migfilin.  The expression of the GFP-
tagged migfilin fragments in the corresponding transfectants was confirmed by Western blotting 
(Fig. 8A, lanes 3-5).   
 
 
 
 
 
Figure 9. The C-terminal LIM domains, but not 
the N-terminal filamin-binding domain or the 
central proline-rich domain, mediate migfilin 
localization to adherens junctions.  (A-D) The 
central proline-rich domain is not required for 
migfilin localization to cell-cell junctions. HaCat 
cells were transfected with expression vectors 
encoding GFPmigfilin (A and B) or GFP-
migfilin(s) (C and D). The cells were stained with 
the rabbit anti-β-catenin primary antibody and 
Rhodamine RedTM-conjugated anti-rabbit IgG 
secondary antibody, and were observed under a 
Leica DM R fluorescence microscope equipped 
with GFP (A and C) or rhodamine (B and D) 
filters. (E-J) The C-terminal LIM domains, but not 
the N-terminal filamin-binding domain, are 
sufficient for mediating migfilin localization to 
adherens junctions. HaCat cells that were 
transiently transfected with expression vectors 
encoding GFP-PR-LIM1-3 (E and F), GFP-LIM1-3 
(G and H) or GFP-N-ter (I and J) were stained with 
the anti-β-catenin antibody or phalloidin as 
indicated. Bar, 8 µm. 
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Analysis of the subcellular localization of the GFP-tagged migfilin mutants showed that 
GFP-PRLIM1-3 (Fig. 9E), like GFP-migfilin (Fig. 9A), was clustered at cell-cell junctions where 
abundant β-catenin was present (Fig. 9F), indicating that the N-terminal domain is not required 
for migfilin localization to cell-cell junctions. Clusters of GFP-LIM1-3 were also detected at β-
catenin-rich adherens junctions (Fig. 9G, H), suggesting that the C-terminal LIM domains are 
sufficient for mediating migfilin localization to adherens junctions.  
 
By contrast, the N-terminal fragment was not clustered at cell-cell junctions but instead it 
associated primarily with the actin ilaments (Fig. 9I, J). Taken together, these results suggest that 
the C-terminal LIM domains, but not the N-terminal domain, mediate migfilin localization to 
cell-cell junctions. 
 
The LIM 2 domain is essential for migfilin clustering at cell-cell adhesions 
To identify the LIM domain within the C-terminal region that is essential for mediating 
migfilin localization to cell-cell junctions, we introduced mutations into different migfilin LIM 
domains (Fig. 8B) and expressed the GFP-tagged migfilin mutants in HaCat cells (Fig. 8A, lanes 
6-10). GFP-LIM1N, in which the first zinc finger in the LIM1 domain was deleted (Fig. 8B), was 
able to cluster at cell-cell junctions (Fig. 10A,B), suggesting that the first zinc finger of LIM1 
domain is not absolutely required for migfilin clustering at these sites. Noticeably, GFP-LIM1N 
also accumulated in the nuclei (Fig. 10A).   
 
However, substitution of C243 or C291 - which are crucial for the folding of the LIM2 
domain (Fig. 8B) - with Gly eliminated the clustering of migfilin at cell-cell junctions, although 
they were still capable of associating with the actin filaments (Fig. 10C-F). Thus, the LIM2 
domain is essential for migfilin clustering at cell-cell junctions.  
 
We next analyzed the localization of migfilin or migfilin(s) mutants bearing a point 
mutation at C306, which is essential for the folding of the first zinc finger of LIM3 (Fig. 10B). 
The localization of migfilin(s) C306G point mutant (Fig. 8G, H, arrows) or that of migfilin 
C306G point mutant (not shown) to the β-catenin-containing cell-cell adhesions was 
compromised, suggesting that LIM3 also plays an important role in the recruitment of migfilin to 
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these sites. The C306G point mutants (Fig. 10G), like the C243G (Fig. 10C) and the C291G (Fig. 
10E) mutants, efficiently associated with the actin filaments, which is reminiscent of that of 
migfilin N-terminal fragment (Fig. 9I). The migfilin(s) C306G point mutant (Fig. 10G), but not 
migfilin C306G point mutant that contains the proline-rich domain (Fig. 11K), was also detected 
in the nuclei.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. LIM2 is essential 
for migfilin localization to 
adherens junctions. HaCat 
cells were transfected with the 
expression vectors encoding 
GFP-LIM1N (A), GFP-C243 
(C), GFP-C291 (E) and GFP-
C306(s) (G). The cells were 
stained with the anti-β-catenin 
antibody as indicated (B, D, F 
and H). Notice that a small 
amount of GFP-tagged 
C306(s) mutant was detected 
in b-catenin-rich adherens 
junctions (G and H, arrows). 
Bar, 8 µm. 
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Mig-2 localizes to cell-ECM but not cell-cell adhesion 
The finding that the C-terminal LIM domains, to which Mig-2 binds, mediate migfilin 
localization to cell-cell junctions prompted us 
to test whether Mig-2 also localizes to cell-
cell junctions. To do this, we stained primary 
human keratinocytes with a monoclonal anti-
Mig-2 antibody. The results showed that Mig-
2 is clustered at cell-ECM adhesions (Fig. 
11A, arrowheads) where actin filaments were 
anchored (Fig. 11B). Mig-2, however, was not 
clustered at junctions between the 
neighboring cells (Fig. 11A, arrow), 
suggesting that Mig-2 is not responsible for 
recruiting migfilin to cell-cell junctions. 
 
Figure 11. Effects of point mutations 
within the LIM domains on migfilin 
localization to cell-ECM adhesions.  (A-D) Mig-
2 localizes to cell-ECM but not cell-cell 
adhesions. Primary newborn human embryonic 
keratinocytes were double stained with mouse 
monoclonal anti-Mig-2 antibody 3A3 (A) and 
phalloidin (B). HaCat cells that were transiently 
transfected with the GFP-migfilin(s) vector (C) 
were stained with the mouse monoclonal anti-
Mig-2 antibody (D). (E-L) HaCat cells that were 
transiently transfected with expression vectors 
encoding GFP-tagged migfilin mutants (as 
indicated) were stained with the mouse 
monoclonal anti-Mig-2 antibody (F, H, J and L). 
Bar, 8 µm. 
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 Furthermore, these results suggest that the binding of Mig-2 to migfilin is insufficient for 
recruiting Mig-2 to cell-cell junctions. The LIM 2 and LIM3 domains, but not the LIM1 domain, 
are required for migfilin clustering at cell-ECM adhesions.  We previously showed that the 
migfilin C-terminal region mediates its localization to cell-ECM adhesions (Tu et al., 2003). The 
specific LIM domains that are involved in the migfilin localization to cell-ECM adhesions, 
however, had not been determined.  
 
To identify the site that mediates migfilin localization to cell-ECM adhesions, we 
transfected HaCat cells with expression vectors encoding the wild-type or mutant forms of 
migfilin (Fig. 8) and stained the transfectants with the monoclonal anti-Mig-2 antibody. The 
results showed that, as expected, GFP-migfilin(s) (Fig. 11C) and GFP-migfilin (not shown) 
localize to cell-cell adhesions as well as cell-ECM adhesions. In addition, abundant 
GFPmigfilin(s) was detected in the nuclei (Fig. 11C).  
 
Consistent with the results obtained with primary keratinocytes (Fig. 11A), Mig-2 was 
co-clustered with migfilin in HaCat cells in cell-ECM adhesions but not cell-cell adhesions or the 
nuclei (Fig. 11D). GFP-LIM1N, which lacks the first zinc finger of the LIM1 domain, was 
clustered at cell-cell adhesions (Fig. 11E, arrows) as well as cell-ECM adhesions (Fig. 11E, 
arrowheads), where Mig-2 was detected (Fig. 11F), suggesting that the first zinc finger of 
migfilin LIM1 domain is not required for the cell-ECM adhesion localization. The C243 (Fig. 
11G), C291 (Fig. 11I), C306 (Fig. 11K) or C306(s) (not shown) mutants, however, were not 
clustered at cell-ECM adhesions where abundant Mig-2 was detected, although they were 
associated with the actin filaments. Thus, LIM2 and LIM3, but not LIM1, are required for 
migfilin clustering at cell- ECM adhesions. 
 
Depletion of migfilin compromises the organization of adherens junctions 
We next tested whether migfilin is required for the proper organization of adherens 
junctions. Human HT-1080 fibrosarcoma cells were selected for these studies because (1) 
previous studies have shown that these cells form extensive β-catenin-containing adherens 
junctions (Chitaev and Troyanovsky, 1997; Sacco et al., 1995), (2) our preliminary studies have 
shown that migfilin is recruited to the β-catenin-containing adherens junctions in these cells (see 
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below) and (3) the level of migfilin in HT-1080 cells can be effectively reduced by RNA 
interference (see below).  
 
To suppress the expression of migfilin, we transfected HT-1080 cells with an siRNA that 
specifically targets migfilin mRNA (Tu et al., 2003). Western blot analyses showed that the 
migfilin siRNA reduced the cellular level of migfilin by more than 50% (Fig. 12A, lanes 1 and 
2). Equal loading was confirmed by probing the same samples with an anti-actin antibody (Fig. 
12B, lanes 1 and 2).  
 
Consistent with previous studies (Chitaev and Troyanovsky, 1997; Sacco et al., 1995), 
abundant β-catenin was detected in HT-1080 cells (Fig. 12C, lane 1). The level of β-catenin, 
unlike that of migfilin, was not reduced in the presence of the migfilin siRNA (Fig. 12C, lane 2), 
further confirming the equal loading and the specificity of the migfilin siRNA. Consistent with 
previous studies (Chitaev and Troyanovsky, 1997; Sacco et al., 1995), extensive β-catenin-
containing adherens junctions were formed in HT-1080 cells that express a normal level of 
migfilin (Fig. 12D, F). 
 
 Immunofluorescent staining of HT-1080 cells with a rabbit polyclonal anti- β-catenin 
antibody and a mouse monoclonal anti-migfilin antibody showed that, as expected, a substantial 
amount of migfilin was co-clustered with β-catenin at cell-cell junctions (Fig. 12, compare F and 
H). Noticeably, suppression of migfilin expression by RNA interference substantially impaired 
the organization of the β-catenin-containing adherens junctions (Fig. 12E, G, I), albeit the total 
cellular level of β−catenin was not reduced in these cells (Fig.12C).  
 
Thus, migfilin is involved in the regulation of the organization of the β-catenin-
containing adherens junctions but not the expression of β-catenin. Interestingly, migfilin-
containing cell-ECM adhesions, unlike adherens junctions, were not eliminated in the migfilin 
siRNA transfectants under the experimental condition used, although they appeared somewhat 
smaller than those in the control cells (Fig. 12J, K). 
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Figure 12. siRNA-
mediated depletion of 
migfilin and its effect on β-
catenin organization.  
Human HT-1080 cells 
that were transfected with the 
migfilin siRNA (lane 2) or the 
control small RNA (lane 1) 
were analyzed by western 
blotting with monoclonal anti-
migfilin antibody (clone 43) 
(A), monoclonal anti-actin 
antibody (B) or a polyclonal 
anti- β-catenin antibody (C). 
(D-K) HT-1080 cells 
transfected with the control 
RNA (D, F, H and J) or the 
migfilin siRNA (E, G, I and 
K) were double stained with 
mouse monoclonal anti-
migfilin antibody (clone 43) 
(H-K) and rabbit-polyclonal 
anti- β- catenin antibody (F 
and G). The differential 
interference contrast (DIC) (D 
and E) and immunofluorescent 
(F-K) images were recorded 
using a Leica DM R 
fluorescence microscope 
equipped with a Hamamatsu 
ORCA-ER digital camera. 
Bar, 8 µm. 
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 We next analyzed the effects of depletion of migfilin on F-actin and cadherin, another 
marker of cell-cell adhesions. To do this, we dually stained the cells with phalloidin and the 
monoclonal anti-migfilin antibody, or a rabbit polyclonal anti- β-catenin antibody and a mouse 
monoclonal anti-cadherin antibody. In control cells that express a normal level of migfilin, 
abundant F-actin was detected at cell-cell junctions where a substantial fraction was associated 
with clusters of migfilin (Fig. 13D, F, H).Furthermore, as expected, β-catenin and cadherin are 
co-clustered at cell-cell junctions(Fig. 13J, L, N).  
 
By contrast, in migfilin siRNA transfectants that express a reduced level of migfilin, the 
actin cytoskeleton was disorganized (Fig. 13, compare H and I) and β-catenin and cadherin 
distributed rather diffusely in the cells (Fig. 13K, M, O). In parallel experiments, western 
blotting analyses showed that the cellular cadherin level (Fig. 13C, lanes 1 and 2), like that of β-
catenin (Fig.12C, lanes 1 and 2), was not significantly reduced in migfilin siRNA transfectants in 
which the expression of migfilin was suppressed (Fig. 13A, lanes 1 and 2). Taken together, these 
results suggest that migfilin is crucially involved in the proper organization of adherens 
junctions. 
 
To further assess the function of migfilin in cell-cell adhesion, we analyzed the parental 
HT-1080 cells, the control RNA transfectants and the migfilin siRNA transfectants using a cell 
dissociation assay. To do this, the cells were detached from culture plates with a rubber 
policeman and passed through Pasteur pipettes ten times. The majority of the migfilin siRNA 
transfectants, which expressed a reduced level of migfilin (Fig. 14A, lane 3), were dissociated 
from each other after pipetting (Fig. 14,C, F).  
 
By contrast, under identical experimental conditions, significantly higher percentages of 
the control cells (i.e. the parental HT-1080 cells and the control RNA transfectants) that express 
a normal level of migfilin (Fig.14A, lanes 1 and 2) remained associated with each other 
(Fig.14D, E, F). Thus, consistent with the disorganization of β−catenin and cadherin (Fig. 13), 
depletion of migfilin weakened the cell-cell association. 
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Figure 13. Depletion of 
migfilin compromises the 
organization of adherens 
junctions. Human HT-1080 
cells that were transfected 
with the migfilin siRNA 
(lane 2) or the control small 
RNA (lane 1) were analyzed 
by western blotting with 
monoclonal anti-migfilin 
antibody (clone 43) (A) or 
an anti-cadherin antibody 
(C). Equal loading was 
confirmed by re-probing the 
migfilin membrane (A) with 
a monoclonal anti-actin 
antibody (B). (D-I) HT-
1080 cells transfected with 
the control RNA (D, F and 
H) or the migfilin siRNA 
(E, G and I) were double 
stained with the mouse 
monoclonal anti-migfilin 
antibody (clone 43) (F and 
G) and Rhodamine-
conjugated phalloidin (H 
and I). The mouse anti-
migfilin primary antibody 
was detected with a FITC-
conjugated anti-mouse IgG 
secondary antibody. (J-O) 
HT-1080 cells transfected 
with the control RNA (J, L 
and N) or the migfilin 
siRNA (K, M and O) were 
double stained with a rabbit 
polyclonal anti-β-catenin 
antibody (L and M) and a 
mouse monoclonal anti-
cadherin antibody (clone 
CH-19) (N and O). The DIC 
(D, E, J and K) and 
immunofluorescent (F-I and 
L-O) images were recorded 
as described in Fig.10. Bar, 
8 µm. 
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Figure 14. 
Depletion of 
migfilin weakens 
the cell-cell 
association. (A,B) 
The parental HT-
1080 cells (lane 1) 
and HT1080 cells 
that were 
transfected with 
the control small 
RNA (lane 2) or 
the migfilin 
siRNA (lane 3) 
were analyzed by 
western blotting 
with the 
monoclonal anti-
migfilin antibody 
(A). Equal loading 
was confirmed by 
re-probing the 
membrane with an 
anti-actin antibody 
(B). (C-F) Cell 
dissociation. The 
migfilin siRNA 
transfectants (C), 
control RNA 
transfectants (D) 
and the parental 
HT-1080 cells (E) 
were detached 
from culture 
plates, passed 
through Pasteur 
pipettes ten times 
and observed 
under an Olympus 
IX70 inverted 
microscope. Bar in 
E, 100 µm. The 
degree of cell 
dissociation (the 
number of particles (Np)/the number of total cells (Nc)) was calculated by analyzing at least 500 cells 
from each sample (F). Bars in F represent means + s.d. from two independent experiments. 
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2.4 DISCUSSION 
Cell-cell junctions are highly specialized subcellular structures that are essential for 
epithelial and endothelial tissue formation and communication between neighboring cells. The 
studies presented in this paper have identified a new component of cell-cell junctions. Migfilin 
was identified and cloned based on its interaction with Mig-2, an important component of cell-
ECM adhesions (Tu et al., 2003). In adherent cells lacking cell-cell junctions, migfilin is largely 
co-localized with Mig-2 at cell-ECM adhesions (Tu et al., 2003).  
 
Using a combination of biochemical, cell biological, immunofluorescence and 
immunoelectron microscopic approaches, we have now shown that in epithelial as well as 
endothelial cells, migfilin localizes not only to cell-ECM adhesions but also to cell-cell 
junctions. In addition to showing that migfilin is a component of cell-cell junctions, we have 
characterized, both temporally and spatially, the localization of migfilin to cell-cell junctions. 
Migfilin localizes to cell-cell junctions soon after calciuminduced clustering of cadherin-â-
catenin complex at these sites, suggesting that the localization of migfilin to cell-cell junctions is 
probably triggered by the presence of cadherin-β- catenin complex at these sites. Importantly, 
immunoelectron microscopic analyses have shown that migfilin is co-clustered with β-catenin at 
cell-cell junctions.  
 
These findings raise an interesting possibility that migfilin binds to β-catenin or other 
components of the cadherin- β-catenin complex at adherens junctions, resulting in the formation 
of a supramolecular complex containing migfilin, β-catenin and other components of adherens 
junctions.  
 
Using an siRNA-mediated knockdown approach, we have found that migfilin is 
functionally indispensable for proper organization of adherens junctions. It is worth noting that 
whereas the migfilin- and β-catenin-containing adherens junctions were largely eliminated in 
HT-1080 cells in which the expression of migfilin is suppressed, a substantial number of 
migfilin-containing cell-ECM adhesions were detected in the cells that lacked migfilin- and β-
catenin-containing adherens junctions. These results suggest that the dynamics of these two 
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migfilin-containing adhesion structures (i.e. cell-cell and cell-ECM adhesions) are probably 
different. Migfilin in the cell-cell adhesions probably has a faster turnover rate than that in cell-
ECM adhesions and therefore inhibition of migfilin synthesis by RNA interference resulted in a 
more dramatic down-regulation of migfilin at cell-cell adhesions and consequently the loss of 
adherens junctions. The loss of adherens junctions induced by the preferential elimination of 
migfilin at cell-cell adhesions in response to siRNA-mediated suppression of migfilin expression 
strongly suggests a direct role of migfilin in the organization or maintenance of the cell-cell 
adhesion structure. Consistent with this, siRNA-mediated depletion of migfilin significantly 
weakened the association of HT-1080 cells.  
 
How does migfilin contribute to the organization or maintenance of adherens junctions? 
One characteristic of the migfilin-containing cell-cell adhesion structure is that it is highly 
resistant to detergent extraction, probably because of its cross-linking with filamentous actin at 
the adhesion sites (Fig. 5). Migfilin interacts with two important actin-binding proteins, VASP 
(Zhang et. al., 2006) and filamin (Tu et al., 2003; Takafuta et al., 2003). VASP, which binds to 
the central proline-rich domain of migfilin, is known to localize to adherens junctions 
(Grevengoed et al., 2002; Vasioukhin et al., 2000). However, VASP is unlikely to be responsible 
for recruiting migfilin to adherens junctions, as migfilin(s), which lacks the VASP-binding 
domain, also localizes to adherens junctions. Although VASP is unlikely to be functioning in 
mediating migfilin localization to adherens junction, it is possible that migfilin, through its 
interaction with VASP, functions in recruiting VASP to adherens junctions. Given the 
importance of VASP in the assembly and functions of epithelia (Comerford et al., 2002; 
Grevengoed et al., 2002; Lawrence et al., 2002; Vasioukhin et al., 2000), it will be interesting to 
test in future studies whether migfilin plays such a role.  
 
Migfilin, through its N-terminal domain, binds to filamin (Tu et al., 2003; Takafuta et al., 
2003). The interaction of migfilin with filamin is probably responsible for the tight association of 
migfilin with actin filaments, as a migfilin fragment containing the filamin-binding N-terminal 
domain but lacking the central proline-rich domain and the C-terminal LIM domains stably 
associates with actin filaments in cells (Fig.9I, J). Filamin cross-links actin filaments and is 
known to be crucial for the organization of the actin cytoskeleton (reviewed by Stossel et al., 
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2001; van der Flier and Sonnenberg, 2001). Additionally, filamin binds to Cdc42, Rac, Rho and 
guanine nucleotide exchange factors that regulate the small GTPases (Bellanger et al., 2000; 
Ohta et al., 1999) and their effectors such as p21-activated kinase (PAK) (Vadlamudi et al., 
2002) and Rho-kinase (ROCK) (Ueda et al., 2003). There is strong evidence now for a crucial 
role of actin polymerization and their regulators such as Cdc42 and Rac in the assembly as well 
as the signaling of cell-cell adhesions (reviewed by Adams and Nelson, 1998; Braga, 2002; 
Jamora and Fuchs, 2002; Perez-Moreno et al., 2003). It is likely that the interaction of migfilin 
with filamin contributes to the organization, maintenance or signaling of the intercellular 
adhesions.  
 
Thus, the identification of migfilin as a functionally important component of adherens 
junctions and its characterization described in this paper shall facilitate future studies aimed at 
fully understanding the organization and signaling of this important adhesion structure.  
 
In the present study, we have also identified the determinants that control migfilin 
localization to cell-cell and cell-ECM adhesions, two functionally coordinated but structurally 
distinct adhesion structures. Both LIM2 and LIM3 are crucially involved in the localization of 
migfilin to cell-cell and cell-ECM adhesions, whereas LIM1 (at least the first zinc finger of 
LIM1) is not required for migfilin localization to either adhesion site.  
 
These results suggest that the sites that control the distribution of migfilin to cell-cell and 
cell-ECM adhesions are largely overlapping. Importantly, Mig-2, which recruits migfilin to cell-
ECM adhesions, is present exclusively in cell-ECM adhesions (Fig. 11). Thus, it is attractive to 
propose a model in which Mig-2 competes with the components of adherens junction for 
interacting with migfilin. In cells with both cell-cell and cell-ECM adhesions, there exist at least 
two pools of migfilin. One pool of migfilin binds to Mig-2, which results in the recruitment of 
migfilin to cell-ECM adhesions, whereas the second pool of migfilin associates with components 
of adherens junction and therefore is recruited to cell-cell adhesions. Thus, an elevation of the 
Mig-2 level could translate into upregulation of migfilin localization to cell-ECM adhesions and 
concomitantly downregulation of migfilin localization to cell-cell junctions. The coupling or 
‘cross-talking’ between cell-cell and cell- ECM adhesions is crucial for several biological and 
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pathological processes including epithelial-mesenchymal transition, wound healing, and 
carcinoma invasion. The ‘competition’ model of migfilin localization to cell-cell and cell-ECM 
adhesions could provide a potential mechanism by which cells coordinately regulate the 
assembly or signaling of cell-cell and cell-ECM adhesions. 
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3.0  THE ROLE OF RAS SUPPRESSOR-1 IN CELL SPREADING AND ADHESION 
3.1 INTRODUCTION 
Cell-ECM interactions are crucial for a number of essential cell functions.  Thus, a better 
understanding of the molecular mechanisms involved is essential.    
 
Ras-suppressor-1 (RSU-1), a potent inhibitor of Ras-induced transformation(Masuelli 
and Cutler, 1996), has been recently shown to interact with PINCH at cell-ECM adhesion sites 
both in Drosophila (Kadrmas et al., 2004) and in mammalian cells(Dougherty et al., 2005).  In 
Drosophila, PINCH and RSU-1 together regulate the dorsal closure during Drosophila 
development(Kadrmas et al., 2004), while in mammalian cells RSU-1 binds to PINCH and 
regulates cell adhesion(Dougherty et al., 2005).   
 
Intrigued by the fact that RSU-1 is strongly associated with PINCH, we wondered 
whether RSU-1 affects other PINCH-related functions as well.  Therefore, we employed two 
different approaches in order to shed more light upon the role of RSU-1 in adhesion-related cell 
functions; first we knocked-down RSU-1 in HeLa cells and in parallel we used the 
overexpression approach.   
 
Our results show that RSU-1 is involved in the regulation of cell spreading which is a 
function in which PINCH is also critically involved.  Interestingly however, RSU-1 does not 
affect cell survival as opposed to PINCH, depletion of which induces apoptosis(Fukuda et al., 
2003a; Tu et al., 1999b; Wu, 1999).  Our results also demonstrate a connection of RSU-1 to the 
Rac activation but further studies are needed in order to further decipher the mechanism 
involved. 
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3.2 MATERIALS AND METHODS 
 
Cell culture 
HeLa cells were used for all the assays in the present study.  Cells were cultured in DMEM 
medium (CellGro) supplemented with 10%FBS, 1%Glutamax and 1%Pennicilin/Strepromycin. 
 
Cell spreading 
Cell spreading was performed in HeLa cells plated on 30µg/ml collagen I, as described 
previously (Tu et al., 2003). 
 
Caspase 3 activity assay 
Apoptosis was assessed by caspase-3 activity measurement using the fluorogenic caspase-3 
substrate VII (Ac-DEVD-aminofluoromethylcoumarin) from Calbiochem (San Diego, CA) 
following the company’s protocol. 
 
RNA interference 
HeLa cells were transfected with two different siRNAs against RSU-1 using Lipofectamine 2000 
from Invitrogen according to the company’s guidelines.  The sequence of the first siRNA against 
RSU-1 is as follows: UUA AAU CCA AGU UUC CUA GUU CUG G and CCA GAA CUA 
GGA AAC UUG GAU UUA A, while the sequence of the second siRNA is: AGA GGU AUU 
UGU AUG UCU CAG AAC G and CGU UCU GAG ACA UAC AAA UAC CUC U. 
 
DNA transfections 
All DNA transfections were performed using Lipofectamine 2000 from Invitrogen according to 
the protocol recommended by the company. 
 
Immunoprecipitation and western blotting analysis 
The immunoprecipitation and western blot analysis was performed as previously described(Tu, 
2003). 
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 Rac activation assay 
HeLa cells were transfected with siRNA against RSU-1 or with Flag-tagged RSU-1 or Flag 
vector using Lipofectamine 2000 (Invitrogen), as indicated.  Forty eight hours after transfection, 
cells were harvested and then plated in 60-mm dishes pre-coated with collagen I, and incubated at 
37 °C for 10 min. Activated Rac was detected using a Rac activation assay kit (Cytoskeleton, 
Inc., Denver, CO) following the manufacturer's protocol, as described previously (Zhang et al, 
2004). 
3.3 RESULTS 
RSU-1 binds to PINCH in HeLa cells 
Ras suppressor-1 (RSU-1) has been recently shown to interact with PINCH both in vivo and in 
vitro, participating in several cell adhesion processes(Dougherty et al., 2005; Kadrmas et al., 
2004).  In order to confirm the binding between RSU-1 and PINCH in HeLa cells as well, we 
transfected the cells with Flag-RSU-1 and subsequently performed an immunoprecipitation with 
anti-Flag antibody.  As shown in Figure 15 a strong binding is detected between RSU-1 and 
PINCH.   
 
 
 
 
 
 
 
Figure 15. RSU-1 binds to PINCH in HeLa 
cells. HeLa cells were transfected with either a 
Flag vector or Flag-tagged RSU-1.  Cells were 
then subject to immunoprecipitation and 
PINCH was detected in the 
immunoprecipitants. 
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 Since PINCH is known to associate with ILK and parvin and form a well-characterized 
stable ternary complex at the cell-ECM adhesion sites(Zhang et al., 2002c), we wondered 
whether RSU-1 also associates with the whole PINCH-ILK-parvin complex at the cell-ECM 
adhesions.  To test that, we performed an immunoprecipitation in HeLa cells using an anti- α-
parvin antibody.  When α-parvin is precipitated, PINCH and ILK are found to be co-
immunoprecipitated with α-parvin, as expected.  Interestingly, RSU-1 is also 
immunoprecipitated with α-parvin, showing that RSU-1 is associated with the PINCH-ILK-
parvin complex (Figure 16).   
 
 
 
 
 
 
 
 
Figure 16. RSU-1 is 
immunoprecipitated 
with α-parvin in HeLa 
cells.  HeLa cells were 
subject to 
immunoprecipitation with 
anti-α-parvin antibody 
and PINCH-1 and RSU-1 
were detected by western 
blotting in the 
immunoprecipitated 
samples. 
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 RSU-1 depletion from HeLa cells has no effect on cell survival but increases cell spreading 
and inhibits cell adhesion 
In order to shed more light upon the role of RSU-1 in the cell, we used the RNA interference 
approach to deplete RSU-1 from HeLa cells.  For that purpose two different siRNAs were used.  
As shown in Figure 17A, RSU-1 was efficiently inhibited.  Inhibition of RSU-1 however, did not 
affect cell survival as shown by caspase 3 activity measurements (Figure 17B).  Interestingly, 
however, RSU-1 inhibition led to an increase in cell spreading (Figure 17C) and a concurrent 
decrease in cell adhesion (Figure 17D). 
Figure 17. Effects of RSU-1 depletion in different cellular functions. A) Western blot showing that 
RSU-1 expression is dramatically inhibited by two different siRNA sequences.  Note that the top non-
specific band is equal in all lanes indicating equal loading.  B) Caspase 3 activity in HeLa cells 
transfected with a non-specific control (NSC) siRNA or the two siRNA against RSU-1.  C) Cell spreading 
in HeLa cells plated on 30µg/ml collagen I.  D) Cell adhesion in HeLa cells also plated on 30µg/ml 
collagen I.   
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RSU-1 overexpression leads to decreased cell spreading and Rac activity 
To further understand the role of RSU-1 in the cell, we employed the overexpression approach.  
Flag-tagged RSU-1 was efficiently overexpressed in HeLa cells (Figure 18A, bottom panel) and 
as with the knocking-down approach, cell survival was not affected by the Flag-RSU-1 
overexpression (Figure 18C).  Interestingly however, Flag-RSU-1 overexpression led to 
decreased cell spreading which is consistent with the increase in cell spreading induced by the 
depletion of RSU-1 (Figure 18B).  To further test this effect on cell spreading, HeLa cells were 
tested for Rac activity which, as shown in Figure 18A, exhibited dramatic decrease in the cells 
that overexpressed Flag-RSU-1 as compared to the vector control (Figure 4A, compare Rac 
activity in the Rac pull down sample of the RSU-1 overexpressing cells to the control and in 
relation to the input in the lysate samples). 
 
Figure 18. RSU-1 overexpression leads to decreased cell spreading and Rac activity and has no 
effect on apoptosis. A) Western blot of the Rac activation assay showing Rac decrease and the efficiency 
of RSU-1 overexpression.  B) Cell spreading in HeLa cells plated on collagen I.  C) Caspase 3 activity in 
HeLa cells overexpressing Flag, or Flag-RSU-1. 
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3.4 DISCUSSION 
RSU-1 has been recently shown to bind to PINCH and function in regulating cell adhesion 
(Dougherty et al., 2005).  Consistent with this finding, our study shows that inhibition of RSU-1 
indeed leads to decreased cell adhesion.  Interestingly, however, we also show that RSU-1 
regulates cell spreading.  More specifically, RSU-1 depletion induces an increase in cell 
spreading while RSU-1 overexression inhibits cell spreading.  Furthermore, overexpression of 
RSU-1 inhibits Rac activation which may provide a mechanism to explain the decrease in cell 
spreading.  Although there is an apparent connection between RSU-1, cell adhesion, and cell 
spreading, more research is required in order to decipher the exact mechanism by which RSU-1 
regulates those processes and the extent in which PINCH is involved in this regulation. 
 
Moreover, it is worth noting that although RSU-1 binds strongly to PINCH, which is 
essential for cell survival, RSU-1 itself does not seem to be directly involved in regulating this 
process since neither inhibition nor overexpression of RSU-1 induces cell death.   
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4.0  PART II:  INTRODUCTION TO LIVER BIOLOGY 
4.1 LIVER ARCHITECTURE AND FUNCTION 
Liver is the second largest organ of the body after skin and it is considered as the “biochemical 
factory of the body” since most of the body’s metabolic activities take place in the liver.  
Therefore, it is not surprising that the liver is one of the most complex organs of the body.  To 
stress the importance of liver for the organism suffices to say that when more than 80% of liver 
function ceases, every other organ system of the body fails. 
 
The liver parenchyma is organized in lobules which are hexagonal and consist of portal 
triads surrounding a central vein (Figure 19).  Hepatocytes, the parechymal cells of the liver, are 
organized in plates around the portal triads.  As shown in Figure 20, each portal triad consists of 
the following three vessels: 
a) the portal vein, which brings to the liver blood enriched with nutrients from the intestines 
b) the hepatic artery, which brings to the liver oxygenated blood from the lungs 
c) the bile duct, which brings bile from the bile canaliculi of the liver to the main extrahepatic 
biliary duct. 
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Figure 19. Lobular architecture of 
the liver. Schematic representation 
of portal triads surrounding a central 
vein in each lobule of the liver. 
 
 
. 
Figure 20. Liver architecture. Schematic representation of a portal triad around a central vein. The 
portal triad consists of a bile duct, a branch of the hepatic artery and a branch of the portal vein.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus, blood comes to the liver from two different sources; from the intestines through the portal 
vein, and from the lungs through the hepatic artery, while blood leaves the liver through the 
hepatic vein.  In the meantime, blood from the portal vein and hepatic artery perfuses through the 
liver sinusoids between hepatocytes (see Figure 20), from the portal triads at the periphery to the 
central vein in the middle of the lobule (Figures 19 and 20). 
 
The main synthetic functions that are performed by the liver are as follows: 
 
 Production of albumin and coagulation proteins to facilitate the process of blood clotting. 
 Production of bile. Bile produced by hepatocytes is secreted into the bile canaliculi which 
are connected to a network of intra-hepatic bile ducts, and through the bile canaliculi is 
transferred and stored in the gallbladder.  From the gallbladder, bile is secreted to the 
intestines through the cystic and common bile ducts.  The sectretion of bile facilitates the 
digestion of food by helping in the absorption of lipids and vitamins. 
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 Regulation of blood glucose by converting the excess glucose into glycogen for storage 
that can be again converted to glucose when needed.  The liver also regulates lipids by 
producing cholesterol which in turn helps in carrying fats from the body. 
 Storage of Vitamin A, D, B12 and iron. 
 Detoxification of blood from toxins that originate from the food or drugs by filtering and 
breaking down the toxic substances in simpler compounds that can be used safely by the 
body. 
4.2 LIVER CELL TYPES 
Hepatocytes are the parenchymal cells of the liver that account for 80% of the cell population in 
the liver and carry out the major liver functions.  They are large and exagonally-shaped and are 
arranged in plates with orientation from the portal triad to the central vein.  The plates are 
separated by sinusoidal capillaries (see Figure 19 and 20) which are lined by endothelial cells.   
Apart from the hepatocytes, liver also consists of non-parenchymal cells which include 4 
different categories of cell types (Michalopoulos and DeFrances, 1997): 
1. stellate cells or Ito cells: they store fat, and vitamin A and produce connective tissue as 
well as certain growth factors such as Hepatocyte Growth Factor (HGF), Transforming 
Growth Factor β1 (TGFβ1). 
2.  Kupffer cells: the macrophages of the liver, which destroy microbes and foreign 
substances by phagocytosis. 
3. biliary epithelial cells or cholangiocytes: they are the cells that line the bile ducts where 
bile is being transferred. 
4. sinusoidal endothelial cells: they are the cells that line the blood vessels and have 
characteristic windows called fenestrae which allow maximal contact between 
hepatocytes and blood. 
Since liver performs such important functions for the homeostasis of the whole body, it is 
essential to learn more about hepatocyte biology and the mechanisms governing fundamental 
processes such as hepatocyte differentiation and survival. 
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5.0  INTEGRIN-LINKED KINASE (ILK) IS INVOLVED IN MATRIX INDUCED 
HEPATOCYTE DIFFERENTIATION 
5.1 INTRODUCTION 
Hepatocytes, the parenchymal cells of the liver, have restricted proliferative capacity when 
maintained in culture and they de-differentiate over time losing both their hepatocyte-specific 
gene expression patterns and their characteristic cellular micro-architecture.  Interestingly, 
addition of hydrated complex matrix preparations (Matrigel: a matrix extract from Engelbreth-
Holm-Swarm (EHS) mouse sarcomas or Type I Collagen Gels)(Kleinman, 1986) over de-
differentiated hepatocytes restores differentiation within three days(Block et al., 1996b; Kim et 
al., 1998).  This highlights the importance of matrix for hepatocyte differentiation and normal 
function.   
 
Signals from the extracellular matrix (ECM) are transmitted to the cells through integrins.  
Integrins in turn associate with a number of integrin-proximal proteins and, through those 
interactions, signals are transduced to actin cytoskeleton or the nucleus, thus enabling the cell to 
respond properly to environmental changes and signals(Hynes, 2002).   
 
Integrin-Linked Kinase (ILK) is an important component of cell-matrix adhesions that 
has been shown to be critically involved in many fundamental cellular processes such as 
survival, and differentiation (Hannigan et al., 2005; Huang et al., 2000; Legate et al., 2006; Li et 
al., 2003; Terpstra et al., 2003; Wu, 2005).  Furthermore, ILK overexpression has been 
associated with anchorage-independent growth, suppression of anoikis, and oncogenic 
transformation in general (Attwell et al., 2000a; Hannigan et al., 1996a; Persad and Dedhar, 
2003; Radeva et al., 1997). 
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 ILK can function as an adaptor protein in the cell and is capable of mediating several 
protein-protein interactions with other cell-ECM adhesion proteins.  For instance, ILK interacts 
with the β1 and β3 subunits of integrin(Hannigan et al., 1996a), thus linking the ECM signaling 
to the intracellular compartment of the cell.  Moreover, ILK has been shown to bind to PINCH 
and α-parvin, which are also focal adhesion proteins, forming a stable ternary complex at the 
cell-ECM adhesions sites(Sepulveda et al., 2005; Wu, 2004b).  In fact, the PINCH-ILK-parvin 
complex is pre-formed and recruited to the cell-ECM adhesion sites as a complex(Zhang et al., 
2002b), and it has been implicated in several crucial cellular processes.  Furthermore, each one 
of the components of the complex has been shown to be crucial for cell survival(Fukuda et al., 
2003a; Fukuda et al., 2003b), and cell spreading.  Interestingly, α-parvin is directly connected to 
actin thus linking the whole PINCH-ILK-parvin complex with the cytoskeleton(Wu and Dedhar, 
2001b).  ILK is also capable of binding to another focal adhesion protein termed Mitogen-
inducible gene 2 (Mig-2) (Mackinnon et al., 2002a), which is important for the regulation of cell 
shape and spreading (Tu et al., 2003b).   
 
Finally, it is worth noting that ILK, as well as PINCH, α-parvin and Mig-2 are all widely 
expressed in the human tissues and well-conserved among different species(Clark et al., 2003; 
Mackinnon et al., 2002a; Wu, 2004b), suggesting an essential role in many different organisms 
and processes. 
 
In the present study, we investigated the role of ILK as well as its binding partners 
PINCH, α-parvin and Mig-2 in hepatocyte differentiation induced by matrix.  Primary 
hepatocytes were isolated from the rat liver by collagenase perfusion and cultured for eight days 
in collagen-coated plates.  As shown previously(Block et al., 1996b), hepatocytes de-
differentiated over time in culture and addition of Matrigel restored differentiation within three 
days.  This model culture system for studying hepatocyte differentiation was previously used to 
determine the expression and distribution of focal adhesion (integrins, Focal Adhesion Kinase, 
paxillin) and cell adhesion molecules (E-cadherin)(Kim et al., 1998), as well as the regulation of 
the β-catenin pathway (Monga, 2006).   
 
 52 
In this study, we show that ILK is present in the rat liver and localizes at the cell-ECM 
adhesion sites of primary rat hepatocytes in culture.  Interestingly, the expression level of ILK in 
whole cell lysates of re-differentiated hepatocytes following Matrigel overlay is reduced, and this 
reduction is even more striking when we examine the Triton-X-100-soluble cellular fraction 
during re-differentiation, suggesting that ILK is involved in cellular control of hepatocyte 
differentiation induced by matrix.  Furthermore, we show that PINCH and α-parvin, the other 
two members of the PINCH-ILK-parvin complex at focal adhesions, follow the same changes in 
solubility and expression level as ILK, while Mig-2, another binding partner of ILK, total 
expression level remains unchanged while the level of Mig-2 in the Triton-X-100-insoluble 
fraction increases and the level of Mig-2 in the Triton-X-100-soluble fraction decreases.  Our 
results suggest that ILK, PINCH, and α-parvin play an important role in the process of matrix-
induced hepatocyte differentiation, as their expression is dramatically changing during this 
process, while Mig-2, which also associates with ILK, seems to be unaffected. 
5.2 MATERIALS AND METHODS 
Antibodies and reagents 
Matrigel was purchased from BD bioscience (BD Bioscience, Bedford, MA).  Plates were coated 
with 10% vitrogen (Cohesion, Palo Alto, CA), and were air-dried under a hood and ultraviolet 
light overnight. 
 
The following primary antibodies were used in this study: mouse monoclonal (mAb) anti-ILK 
antibody (clone 69), rabbit polyclonal anti-PINCH, mAb anti-α-parvin (clone3B5), mAb anti-
Mig-2 antibody as described previously(Fukuda et al., 2003a; Fukuda et al., 2003b; Tu et al., 
2003b), sheep anti-rat albumin (Immunology Consultants Laboratory, Newberg, OR), and anti-β-
actin mAb (Chemicon, Temecula, CA).  All secondary Abs were from Jackson ImmunoResearch 
Laboratories (West Grove, PA).  
 
Hepatocyte isolation from rat liver and Matrigel overlay 
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Primary rat hepatocytes were isolated from male Fischer 344 rat livers by a calcium two step 
collagenase perfusion technique, as described previously(Block et al., 1996b).  Freshly isolated 
hepatocytes were plated at a density of 400,000 cells per ml, on collagen-coated 6-well plates, in 
MEM medium (Sigma, St. Louis, MO) supplemented with 500 ng/ml insulin and 50 mg/ml 
gentamycin.  Three to four hours after plating, the medium was replaced with Hepatocyte 
Growth Medium (HGM) containing 40 ng/ml Epidermal Growth Factor (EGF) and 20 ng/ml 
Hepatocyte Growth Factor (HGF) as described previously(Block et al., 1996b).  The rat 
hepatocytes were kept in culture for a total of 15 days and the HGM medium was changed every 
two days.   
 
Rat hepatocytes in half of the plates were overlaid with diluted Matrigel on the eighth day 
following the liver perfusion (Day 0 corresponds to the day of the perfusion), and cultured for 
one week, while the rest of the hepatocytes were maintained in normal culture conditions without 
Matrigel treatment.  Matrigel was diluted 1:3 with HGM, and the medium was changed in all 
cultures every two days. 
 
Immunofluorescent staining 
Immunofluorescent staining was performed as described previously.  Briefly, cells were plated 
on collagen-coated coverslips, fixed with 4% paraformaldehyde and stained with the anti-ILK 
mouse monoclonal antibody (clone 69) or anti-Mig-2 mouse monoclonal antibody.  A 
rhodamine-red conjugated goat anti-mouse antibody was used as a secondary antibody (Jackson 
ImmunoResearch Laboratories (West Grove, PA).  
 
Immunohistochemistry 
Immunohistochemical staining for ILK and Mig-2 was performed on formalin-fixed paraffin 
embedded livers, as described previously (Kim et al., 2000). 
 
Protein isolation and immunoblotting analysis 
Total cell lysates were isolated from Matrigel-treated primary rat hepatocytes at different time 
points following the overlay of Matrigel (Days 10 and 15) and at the same time points lysates 
were isolated from untreated cultures.  Whole cell lysates were generated using 1% sodium 
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dodecyl sulfate (SDS) in RIPA buffer (20 mM Tris/Cl  pH 7.5, 150 mM NaCl, 0.5% NP-40, 1% 
TX-100, 0.25% Sodium Deoxycholated (DOC), 0.6-2 µg/ml aprotinin, 10µM Leupeptin, 1µM 
Pepstatin).  The Triton-X-100-soluble fractions were isolated by lysing the cells for 30min on ice 
in RIPA buffer without SDS, followed by centrifugation at 14,000rpm for 15 min, and collection 
of the supernatant.  The pellet from that centrifugation was then dissolved in RIPA buffer 
supplemented with 1% SDS, and it constituted the Triton X-100-insoluble fraction. 
 
Protein concentrations of all lysates were determined using the bicinchoninic acid protein 
assay reagents (BCA method) (Pierce Chemical Co., Rockford, IL).  Lysates were run on 10% 
reducing SDS-polyacrylamide gels.  Actin was used as a loading control.  
5.3 RESULTS AND DISCUSSION 
ILK and Mig-2 are both present in the liver and they localize at the cell-ECM adhesions of 
primary rat hepatocytes in culture 
In order to determine the expression and localization of ILK, PINCH, α-parvin and Mig-
2 in the liver, we performed immunohistochemical staining on formalin-fixed paraffin-embedded 
liver sections.  Only the anti-ILK and anti-Mig-2 antibodies worked for that purpose.  As shown 
in Figure 21, both ILK and Mig-2 are present in the liver (Fig.21A-C).  In fact, Mig-2 appears to 
be more concentrated in the periportal and centri-lobular regions (Fig.21C). 
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Figure 21: Immunohistochemical localization of ILK and Mig-2 in the liver. A) Formalin-fixed-
paraffin embedded liver sections from normal rat liver were stained with anti-ILK antibody (20X 
magnification), B) Formalin-fixed-paraffin embedded liver sections from normal rat liver were stained 
with anti-ILK antibody (40X magnification), C) Formalin-fixed-paraffin embedded liver sections from 
normal liver were stained with anti-Mig-2 antibody (10X magnification). 
 
Both ILK and Mig-2 have been shown to be present in the cell-ECM adhesions sites of 
multiple cell types (Li et al., 1999b; Tu et al., 2003b).  To test whether the localization is the 
same in hepatocytes, we performed cell immunostaining of primary rat hepatocytes cultured on 
collagen.  Indeed, both ILK (Fig.22B) and Mig-2 (Fig.22C) are abundant in primary cultured rat 
hepatocytes, forming nice and strong focal adhesions.  A picture of the cells stained with just the 
secondary antibody (Fig.22A) serves as negative control for the cell immunostaining. 
 
 
 
 
 
 
 
Figure 22: Localization of ILK and Mig-2 at the cell-ECM adhesions of primary rat hepatocytes. 
Primary rat hepatocytes stained with A) the secondary antibody only (as a negative control), B) the anti-
ILK antibody, C)  the anti-Mig-2 antibody. 
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Differentiation of hepatocytes is restored following addition of Matrigel 
Intrigued by the finding that ILK is abundant at the cell-ECM adhesion sites of primary 
hepatocytes in culture, we sought to find whether its total expression level changes during 
hepatocyte differentiation induced by matrix.  For that purpose, primary rat hepatocytes were 
cultured for eight days in collagen-coated plates using the chemically defined hepatocyte growth 
medium (HGM), which allows serum-free clonal expansion of primary hepatocytes in the 
presence of hepatocyte growth factor (HGF) and epidermal growth factor (EGF)(Block et al., 
1996b).  During that time primary hepatocytes lost albumin gene expression (Fig.23, compare 
albumin in lane 1 with lanes 2 and 3) as described previously(Block et al., 1996b).  On the eighth 
day, Matrigel was added on half of the plates with the de-differentiated hepatocytes and re-
differentiation occurred as shown by the increased albumin expression (Fig.23, compare lane 2 
and 3 to lane 4) as well as the characteristic hepatocyte morphology (data not shown).  Albumin 
was used as a hepatocyte-specific differentiation marker and the results were consistent with 
previous studies done in the same model system of matrix-induced hepatocyte 
differentiation(Block et al., 1996b; Kim et al., 1998), demonstrating that Matrigel overlay indeed 
restores hepatocyte differentiation. 
 
 
 
 
 
 
 
 
 
Figure 23: Hepatocytes re-differentiate in culture following addition of Matrigel, and ILK total 
expression level is reduced. Western blot of total cell lysates from hepatocytes harvested on Days 1, 8 
and 10 following isolation from the liver.  Matrigel was added on Day 8.  Western blot using an anti-rat-
albumin antibody (upper panel) or the anti-ILK antibody (bottom panel). Note that the same membrane 
was first probed with ILK and then reprobed without stripping with the anti-rat albumin antibody.   
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In order to investigate the role of ILK in this process, we analyzed the total protein level 
of ILK in de-differentiated and re-differentiated hepatocytes.  As shown in Figure 23, ILK total 
level was significantly reduced following Matrigel overlay in primary cultured hepatocytes 
(Fig.23, compare lanes 3 and 4), while albumin level has been restored to the initial levels.  This 
result suggests that ILK is involved in the cellular control of hepatocyte differentiation induced 
by matrix, and that a relatively low level of ILK is characteristic of differentiated hepatocytes. 
 
The total protein expression of ILK, PINCH, and α-parvin is reduced during the matrix-
induced hepatocyte differentiation, while the level of Mig-2 is not affected 
To gain further knowledge on the role of ILK in the matrix-induced hepatocyte 
differentiation, we analyzed the total expression level of the ILK-binding proteins, PINCH, α-
parvin and Mig-2.  As shown in Figure 4, the total levels of all three components of the PINCH-
ILK-parvin complex were reduced following addition of Matrigel over de-differentiated 
hepatocytes (Fig.24, compare lanes 2 and 3, for ILK, PINCH, and α-parvin).  Interestingly, 
however, the total expression level of Mig-2, another ILK-binding protein, was not affected 
(Fig.24, compare lanes 2 and 3 for Mig-2).   
 
 
Figure 24: Total 
expression level of PINCH, ILK, 
α-parvin and Mig-2 during the 
matrix-induced hepatocyte 
differentiation. Western blot 
analyses of whole cell lysates from 
primary rat hepatocytes treated with 
matrigel on Day 8 post isolation, 
using antibodies against ILK, 
PINCH, α-parvin, and Mig-2. β-
actin serves as a loading control. 
 
 
In a study by Kim et al. (Kim et al., 1998) using the same model system, it was shown 
that the expression level of paxillin and Focal Adhesion Kinase (FAK), two other focal adhesion 
proteins, is increased in the Matrigel-treated hepatocytes.  Thus, the data of the present study and 
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the study by Kim et al., suggest that during the matrix-induced hepatocyte differentiation, there 
is an interesting re-distribution of the different focal adhesion molecules, and some are increased 
while others are decreased as a response to Matrigel overlay and matrix in general.  Therefore, 
understanding the regulation or the mechanism behind it would provide new insights into 
hepatocyte biology and thus facilitate hepatocyte-oriented therapeutic approaches.  
 
The expression levels of ILK, PINCH and α-parvin are dramatically reduced in the Triton-X-
100-soluble cellular fraction during hepatocyte differentiation 
To shed more light upon the mechanism regulating this complex process of matrix-
induced hepatocyte differentiation, we examined the intracellular distribution of ILK, PINCH, 
and α-parvin during the re-differentiation process.  Triton-X-100-soluble cellular fractions, 
which contain the cytosol, were isolated from dedifferentiated or re-differentiated primary rat 
hepatocytes (at least 3 days following the addition of Matrigel).  As shown in Figure 25, ILK and 
PINCH levels were dramatically reduced in the re-differentiated hepatocytes following Matrigel 
overlay (Fig.25, A, and B), and α-parvin follows the same pattern.  However, the anti-α-parvin 
antibody is far stronger than the anti-ILK or anti-PINCH and thus the change seems less 
dramatic (Fig.25C).  Examination of the actin loading though shows clearly that α-parvin level is 
also reduced in the Triton-X-100-soluble cellular fraction.  These findings show that all members 
of the PINCH-ILK-parvin complex are dramatically downregulated from the cytosol during the 
matrix-induced hepatocyte differentiation, suggesting a biological relevant role of the PINCH-
ILK-parvin complex in hepatocyte biology and the process of differentiation. 
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 Figure 25: 
Expression level 
of ILK, PINCH, 
and α-parvin in 
the Triton-X-
100-soluble 
cellular fraction 
during the 
matrix-induced 
hepatocyte 
differentiation. 
Triton-X-100-
soluble fractions 
from 
dedifferentiated 
and re-
differentiated 
hepatocytes 10 
and 15 days after 
the addition of 
Matrigel (MTG) 
were subject to 
western blot 
analysis for A) 
ILK, B) PINCH, 
C) α-parvin. β-
actin is used as a loading control. 
 
 
Consistent with the above, a similar reduction in ILK in the Triton-X-100 soluble cellular 
fraction was also observed during the myogenic differentiation(Huang et al., 2000), indicating 
that ILK plays an important role in differentiated cells and corroborating the finding of the 
present study. 
 
Intracellular redistribution of Mig-2 during matrix-induced hepatocyte differentiation 
Finally, we sought to determine the cellular distribution of Mig-2, whose total expression 
level was not affected by the Matrigel overlay (Fig.24).  Thus, Mig-2 expression level was 
examined both in the Triton-X-100-soluble fractions, and Triton-X-100-insoluble fractions.  As 
shown in Figure 26, Mig-2 was significantly reduced in the Triton-X-100-soluble or cytosolic 
fraction (Fig.26A), while it was increased in the Triton-X-100-insoluble fraction (Fig.26B), 
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which explains why there was no significant change in the total expression level of Mig-2 
(Fig.24). 
 
 
 
 
 
 
 
 
 
 
Figure 26: Mig-2 cellular re-
distribution following the 
matrix-induced hepatocyte 
differentiation. Triton-X-100-
soluble (A) and insoluble 
fractions (B) from dedifferentiated 
and re-differentiated hepatocytes 
after the addition of Matrigel 
(MTG) were subject to western 
blot analysis for Mig-2. β-actin is 
used as loading control. 
 
 
 
 
 
 
 
In conclusion, it is worth noting that all proteins examined in this study, namely ILK, 
PINCH, α-parvin and Mig-2 have reduced expression levels in the Triton-X-100-soluble cellular 
fractions which correspond to the cytosol.  In contrast, other focal adhesion proteins such as 
FAK, and paxillin (Kim et al., 1998), are elevated in those fractions, indicating the complexity of 
the mechanism regulating the matrix-induced hepatocyte differentiation.  Furthermore, Mig-2 is 
increased in the Triton-X-100-insoluble fraction that is associated with the cytoskeleton 
suggesting that during the matrix-induced hepatocyte differentiation, different focal adhesion 
proteins are differently distributed within the cell, highlighting the complexity of the mechanism 
and the importance of cell-ECM adhesion proteins in this process. 
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In the present study, we have shown that the redistribution of components of the cell-
ECM adhesion molecules is an important element of restoring differentiation in Matrigel-treated 
hepatocyte cultures.  Although the molecular mechanisms governing the hepatocyte 
differentiation process are far from being deciphered, the present work provides new insight that 
could enhance our understanding of the whole process, and ultimately enable us to apply this 
information in the field of cell transplantation of hepatocytes in critically ill liver patients or 
other hepatocyte-based therapies.  
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6.0  LOSS OF INTEGRIN-LINKED KINASE FROM MOUSE HEPATOCYTES IN 
VITRO AND IN VIVO RESULTS IN APOPTOSIS AND HEPATITIS 
6.1 INTRODUCTION 
Extracellular matrix (ECM) is of great importance for the survival, differentiation, and normal 
function of the cells within a tissue.  This is particularly true for hepatocytes, the parenchymal 
cells of the liver (Block et al., 1996b; Kumaran et al., 2005; Otsu et al., 2001; Pinkse et al., 
2004).  In fact, hepatocytes in culture maintained in the absence of matrix rapidly lose patterns of 
hepatocyte-specific gene expression and characteristic cellular micro-architecture.  Interestingly, 
however, when hydrated complex matrix preparations (Matrigel: a matrix extract from 
Engelbreth-Holm-Swarm (EHS) mouse sarcomas or Type I Collagen Gels)(Kleinman, 1986) are 
added over de-differentiated hepatocytes, differentiation is restored within three days (Block et 
al., 1996b; Kim et al., 1998).   
 
Moreover, ECM remodeling is an essential part of liver regeneration after partial 
hepatectomy (Kim et al., 1997; Michalopoulos and DeFrances, 1997; Mohammed, 2005), again 
highlighting the importance of ECM for the normal function of hepatocytes in liver. 
 
Signals from the ECM are transmitted to the interior of the cell via integrins.  Integrins 
not only interact with components of the ECM and physically link them to the cytoskeleton, but 
they also associate with multiple receptor-proximal proteins, which in turn serve as scaffolds for 
the attachment of enzymes that modify and regulate these complex interactions (Hynes, 2002).  
  
Integrin-Linked Kinase (ILK) is a Ser/Thr kinase that is emerging as a key regulator of 
cell-ECM adhesions.  Activation of ILK, either by integrin clustering or by growth factors, 
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affects multiple cell signaling pathways that regulate different processes such as survival, 
differentiation, proliferation, migration, and angiogenesis (Friedrich et al., 2004a; Huang et al., 
2000; Tan et al., 2004a; Terpstra et al., 2003).  Additionally, there is evidence that ILK also 
plays a role in oncogenic transformation (Hannigan et al., 1996a; Radeva et al., 1997; 
Yoganathan et al., 2002a).   
 
From the signaling perspective, ILK activation results in the phosphorylation and 
subsequent activation of protein kinase B (PKB/Akt) (Persad et al., 2000a; Troussard et al., 
2003b; Wu and Dedhar, 2001b)  and Mitogen Activated Protein Kinase (Wu and Dedhar, 
2001b), as well as inhibition of Glycogen Synthase Kinase 3-beta (Delcommenne et al., 1998b; 
Tan et al., 2001a).  Through these pathways, ILK regulates survival, differentiation, cell cycle 
progression and many other crucial processes. 
 
As an adaptor protein, ILK mediates multiple protein-protein interactions (Wu, 2001a; 
Wu, 2004b).  Apart from interaction with the β1-and β3-subunits of integrin (Hannigan et al., 
1996a), ILK also binds to PINCH (Li et al., 1999b; Tu et al., 1999a) and α-parvin, member of 
the CH-ILKBP/α-parvin/actopaxin/affixin protein family (Fukuda et al., 2003a; Tu et al., 2001b; 
Zhang et al., 2002b; Zhang et al., 2002), resulting in the formation of a ternary complex within 
cells.  This stable ternary complex of PINCH-ILK-parvin at the cell-ECM adhesion sites, has 
been shown to be crucial for cell survival (Fukuda et al., 2003a; Fukuda et al., 2003b; Tu et al., 
2001b; Tu et al., 1999a).  
 
Although, extensive research has been done on ILK signaling and functions in the cell, 
little is known about the function of ILK in hepatocytes.  There is, however, evidence suggesting 
that integrin signaling is important for hepatocyte survival (Pinkse et al., 2005; Pinkse et al., 
2004; Su, 2005).   
 
Our aim in the present study was to elucidate the role of ILK in mouse hepatocytes both 
in vitro and in vivo.  In order to pursue this, we utilized the loxP-Cre system to directly eliminate 
ILK from primary mouse hepatocytes in culture or from the whole animal.   
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6.2 MATERIALS AND METHODS  
Antibodies 
The following primary antibodies were used in this study: mouse monoclonal (mAb) anti-ILK 
antibody (clone 69) (Santa Cruz biotechnology, Santa Cruz, CA), rabbit polyclonal anti-
PINCH1, mAb anti-α-parvin (clone3B5), mAb anti-Mig-2 antibody as described previously(Tu 
et al., 2001b; Tu et al., 2003b), rabbit polyclonal anti-phospho-Akt (Ser 473) (Cell Signaling 
Technology, Danvers, MA), and anti-β-actin mAb (Chemicon, Temecula, CA).  All secondary 
Abs were from Jackson ImmunoResearch Laboratories (West Grove, PA).  
 
Animals 
The ILK-floxed animals that were used in the present study were generated as described 
previously(Terpstra et al., 2003).  All animals were housed in the animal facility of the 
University of Pittsburgh and they were treated in a humane manner according to the criteria 
outlined in the “Guide for the Care and Use of Laboratory Animals” prepared by the National 
Academy of Sciences and published by the National Institutes of Health.  All experiments were 
performed under protocols approved by the Institutional Animal Care and Use Committee 
(IACUC) of the University of Pittsburgh. 
 
Eight wild type animals, purchased from the Jackson Laboratory (Bar Harbor, Maine), 
were used to investigate the inherent toxicity of the injected Cre-expressing adenovirus.  As the 
ILK-floxed animals were on a mixed genetic background, four of the controls were of the 
129X1/SvJ strain and the remaining four were of the C57BL/6J strain. 
 
Isolation of hepatocytes from the mouse liver 
Mouse hepatocytes from the ILK-floxed animals were isolated by an adaptation of the calcium 
two step collagenase perfusion technique, as described previously(Block et al., 1996b).  
Hepatocytes were plated at a density of 300,000 cells per ml, in 6-well (35mm) plates, and the 
medium was renewed 3-4h after plating.  The medium used was MEM (Sigma, St. Louis, MO) 
supplemented with 10% fetal bovine serum (FBS), 1% glutamine, and 1% penicillin and 
streptomycin. 
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 Adenoviral vectors  
The recombinant adenoviruses used in this study were either control adenoviral expression 
vector encoding β-galactosidase (β-gal), Cre-recombinase-expressing adenovirus (Cre), or 
adenoviral expressing vector encoding a FLAG-tagged full length mouse ILK.  The control β-gal 
adenovirus was kindly provided by Drs. Tong-Chuan He and Bert Vogelstein (Howard Hughes 
Medical Institute, The Johns Hopkins Oncology Center, Baltimore, MD).  The Cre expressing 
adenovirus was kindly provided by Dr. Jorge Sepulveda (Department of Pathology, University of 
Pittburgh School of Medicine).  
 
The FLAG-tagged full length mouse ILK expressing adenovirus was generated by 
cloning the cDNA encoding the FLAG-tagged full length mouse ILK into the SalI/XbaI sites of 
the pAdTrack-CMV shuttle vector and mixed with supercoiled pADEsay-1, as previously 
described (29).  
 
The amplified adenoviruses were subsequently purified by cesium chloride (CsCl) 
density gradient ultracentrifugation, dialyzed in sterile virus storage buffer, aliquoted, and stored 
at –80°C until use (Graham, 1991; Kolls, 1994).  Viral titers were initially calculated by 
measuring the optical density of the viral DNA at 260 nm (OD260).  Titer was considered equal to 
the optical density at 260nm divided by 9.09 × 10 13 particles/ml.   
 
However, before using the adenovirus in our cultured cells, we also measured the viral 
titer by plaque formation assay (pfu/ml) performed according to the protocol provided by BD 
biosciences.   
Adenoviral infections of ILK-floxed mouse hepatocytes in culture 
Twenty four hours after liver perfusion (Day 1), the cultured ILK-floxed mouse hepatocytes 
were infected with 107pfu/well of either control β-gal or Cre adenovirus.  The medium was 
changed the following day and cells were kept in culture for a total of seven days.  
 
For the rescue experiments, hepatocytes were co-infected with either β-gal adenovirus 
and ILK-adenovirus, or Cre adenovirus and ILK adenovirus, one day after isolation from the 
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mouse liver.  The viral titer used for these experiments was 107 pfu/well for the β-gal and Cre 
adenoviruses, and 8x106 pfu/well for the ILK adenovirus. 
 
Tail vein injections of adenoviral expressing vectors in ILK-floxed animals  
PBS, 1010 particles/mouse (109 pfu/mouse) of control β-gal adenovirus, Cre-expressing 
adenovirus, or vehicle only (phosphate buffered saline) as an additional control, were 
administered into 78 ILK-floxed mice via tail vein injection.  The same number of viral particles 
of Cre adenovirus was also injected via tail vein in eight wild type animals to test for the inherent 
toxicity of the Cre-recombinase. 
 
Immunofluorescent staining 
Immunofluorescent staining was performed as described previously (Li et al., 1999b; Tu et al., 
2003b).  Briefly, cells were plated on collagen-coated coverslips, fixed with 4% 
paraformaldehyde and stained with the anti-ILK mouse monoclonal antibody (clone 69).  A 
rhodamine-red conjugated goat anti-mouse antibody was used as a secondary antibody. 
 
Histology scoring 
Hematoxylin-and-eosin (H&E) staining was performed both on formalin-fixed-paraffin-
embedded sections, and paraformaldehyde-fixed frozen sections of the livers from ILK-floxed 
mice injected with β-gal or Cre-adenovirus.  The histology was evaluated in a blind fashion by 
the pathologist (G.K.M.) and scored according to the following characteristics: Score 0; normal 
liver, Score 1; inflammation and/or fatty change, Score 2; inflammation and/or fatty change, with 
very few apoptotic cells, Score 3; inflammation and/or fatty change, with apoptosis, Score 4; 
inflammation, and/or fatty change, apoptosis, ballooning degeneration, and abnormal mitoses, 
Score 5; inflammation, and/or fatty change, apoptosis, ballooning degeneration, abnormal 
mitoses, hydropic degeneration, and necrosis. 
 
Polymerase Chain Reaction (PCR) 
DNA was isolated from the ILK-floxed mouse hepatocytes using the Trizol reagent from 
Invitrogen (Carlsbad, CA).  Subsequently, the DNA was tested by PCR using a set of primers 
designed to detect the deleted ILK gene; forward: 5'-CCA GGT GGC AGA GGT AAG TA-3', 
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reverse: 5'-CAA GGA ATA AGG TGA GCT TCA GAA-3'.  The conditions of the PCR reaction 
were as follows: 94oC for 5min, 94 oC for 1min, 55 oC for 1min, 72 oC for 3 min, (40 cycles for 
the last three steps), 72 oC for 10min, 55 oC for 5min and hold at 4 oC.  The PCR products were 
separated through a 1% agarose gel at 80V for 4h and visualized with eithidium bromide 
staining. 
 
DNA was also isolated from livers of ILK-floxed mice injected with either PBS, β-gal-
adenovirus, or Cre-expressing adenovirus using again the Trizol reagent.  Subsequently, the 
DNA was subject to PCR using the following primers for the amplification of the Cre gene; 
forward: 5'- GCG GTC TGG CAG TAA AAA CTA TC-3', reverse: 5'- GTG AAA CAG CAT 
TGC TGT CAC TT -3'.  The conditions of the PCR reaction were as follows: 94oC for 3min, 94 
oC for 30sec, 68 oC for 1min, 72 oC for 1min, (35 cycles for the last three steps), 72 oC for 2min, 
and hold at 10 oC.  The PCR products were separated using a 2% agarose gel at 80V for 2h and 
visualized with ethidium bromide staining. 
 
Protein isolation for immunoblotting 
Total protein was isolated from the ILK floxed mouse hepatocytes or livers of the ILK-floxed 
mice injected with PBS, β-gal or Cre-expressing adenovirus using 1% sodium dodecyl sulfate 
(SDS) in RIPA buffer (20 mM Tris/Cl  pH 7.5, 150 mM NaCl, 0.5% NP-40, 1% TX-100, 0.25% 
Sodium Deoxycholated (DOC), 0.6-2 µg/ml aprotinin, 10µM Leupeptin, 1µM Pepstatin).   
 
Caspase-3 activity measurement 
Apoptosis was assessed by caspase-3 activity measurement as described in the materials and 
methods section in Chapter 3. 
TUNEL assay 
Apoptosis in livers from adenovirus-injected animals was assessed by terminal 
deoxynucleotidyltransferase-mediated dUTP-biotin nick end-labeling (TUNEL) assay using the 
ApopTag In Situ Apoptosis Detection Kit from Chemicon (Temecula, CA).  
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6.3 RESULTS 
ILK is localized to the cell-ECM adhesions of primary mouse hepatocytes in culture 
ILK has been shown to localize to the cell-ECM adhesions in a number of different cell types (Li 
et al., 1999b).  In order to test whether the localization of ILK is the same in hepatocytes, we 
stained primary mouse hepatocytes with anti-ILK monoclonal antibody.  ILK is indeed abundant 
at the cell-ECM adhesion sites in primary mouse hepatocytes (Fig.27A), and it also appears to be 
present in the canaliculi formed between hepatocytes in culture (Fig.27B). 
 
 
 
 
Figure 27: Localization of ILK to the cell-ECM adhesions of primary hepatocytes. A, and B) 
Primary hepatocytes stained with anti-ILK antibody.   
 
 
ILK gene and protein are removed by infection of the ILK-floxed mouse hepatocytes with Cre 
adenovirus 
To test the significance of ILK in hepatocytes, we employed the loxP-Cre system 
approach.  Specifically, primary mouse hepatocytes were isolated from ILK-floxed mice by liver 
perfusion (Day 0) and twenty four hours after plating (Day 1), cells were subject to adenovirus 
infections to introduce either Cre-recombinase (Cre-adenovirus) or β-galactosidase (β-gal 
adnovirus) as a control.  DNA was isolated from the adenovirus-infected cells and subsequently 
tested by PCR using a set of primers designed to detect the excised ILK gene.   
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Figure 28: Excision of the ILK gene and removal of the ILK protein from primary ILK-floxed 
mouse hepatocytes. A) PCR products showing the excised ILK gene (arrow) in the cells-infected with 
Cre-adenovirus 2, 3, and 4 days post-infection (lanes 5-7). Note that the uninfected cells (lanes 1 and 2), 
and the β-gal-infected cells (lanes 3 and 4) do not have the excised ILK band, B) Western blot showing 
that ILK protein is not removed from the uninfected cells (lanes 1, 2, 5 and 8), nor the β-gal-infected cells 
(lanes 4, 7 and 10), but it is removed from the Cre-infected cells 4 days post-infection with Cre 
adenovirus (compare lane 9 to lanes 3 and 6).  Actin is used as loading control. 
 
 
As shown in Figure 28A, the ILK gene was excised by the Cre-recombinase as early as 
one day after infection of the cells with Cre-adenovirus (Day 2).  The ILK protein however, was 
not completely depleted until day 4, as shown in Figure 28B. 
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Depletion of ILK from ILK-floxed mouse hepatocytes leads to massive apoptosis 
The ILK-floxed mouse hepatocytes that were infected with control β-gal adenovirus 
exhibited normal hepatocyte morphology for at least five days in culture.  On the other hand, the 
ILK-floxed hepatocytes that were infected with an equal number of plaque forming units 
(pfu/ml) of the Cre-adenovirus showed abnormal morphology, and increasing numbers of dead 
cells were observed over time.  The accumulation of dead cells in the Cre-infected-ILK-floxed 
hepatocytes started on day 3 (two days following infection with Cre-adenovirus), as shown in 
Figure 36A.  
 
In order to determine whether the cells were dying as a result of apoptosis, caspase 3 
activity was measured at different time points after infection.  Starting on day 3 following 
adenoviral infections, caspase 3 activity was 4-9 fold increased in the Cre-infected cells 
compared to the uninfected cells or the cells infected with the control β-gal adenovirus  
(Fig.29B, compare the solid black bars with the solid white or striped bars).  
 
These results suggest that ILK is crucial for hepatocyte survival since depletion of the 
protein from primary cultured hepatocytes leads to massive apoptosis.  
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 Figure 29: Cell 
morphology and 
caspase 3 activity in 
mouse hepatocytes 
following ILK 
knock-down. A) 
Cell morphology of 
uninfected (
control-adenovirus 
(β-gal)-infected, or 
Cre-infected 
hepatocytes, 2, 3, 4 
and 5 days post-
infection.  Cells were 
observed under an 
Olympus IX70 
fluorescence 
microscope and 
images were 
captured with a 
digital camera.  Note 
that the parental or 
β-gal-infected 
hepatocytes have 
normal morphology 
during days 2-5, 
while the Cre-
infected hepatocytes 
show increasing 
numbers of dead 
cells over time,  B) 
Caspase 3 activity 2, 
3, 4, and 5 days post-
infection.  Cre-
infected hepatocytes 
have significantly 
elevated caspase 3 
activity compared to 
the parental and 
control infected 
cells.  Compare the 
solid black bars with 
the solid white or 
striped bars.     
parental), 
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ILK overexpression substantially rescues apoptosis induced by the removal of ILK 
We next sought to find whether the effect of ILK depletion on apoptosis could be rescued 
via re-introduction of the protein.  Cells were co-infected with either β-gal adenovirus and an 
adenovirus expressing ILK (ILK-adenovirus), or Cre-adenovirus and ILK-adenovirus, and 
harvested four days after infection for western blot analysis.  As shown in Figure 4A, ILK was 
effectively removed by the Cre-recombinase (Fig.30A, lanes 3 and 5) and it was efficiently 
overexpressed in the cells that were co-infected with ILK-adenovirus (Fig.30A, lanes 4 and 5). 
 
  Interestingly, parallel caspase 3 activity measurement experiments for the same sets of 
cells revealed a reduction of approximately 36% in the caspase 3 activity in the cells that were 
co-infected with Cre and also overexpressed ILK, compared to the ones that were solely infected 
with the Cre adenovirus.  This indicates that the dramatic apoptotic effect in the Cre-infected-
ILK-floxed hepatocytes results from the loss of ILK. 
Figure 30: ILK 
overexpression 
substantially 
rescues the 
effect on 
apoptosis 
induced by the 
loss of ILK.A) 
Western blot 
showing ILK 
knock-down 
(lanes 3 and 5), 
and 
overexpression 
(lanes 4 and 5), 
four days post-
infection.  B) 
Caspase 3 
activity four 
days post 
infections. The 
same sets of 
cells were used 
for A and B. 
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PINCH-1 and a-parvin expression levels are reduced in the ILK-depleted hepatocytes 
To further investigate the mechanism by which ILK removal induces apoptosis in 
hepatocytes, we first sought to determine whether ILK-associated proteins are affected.  To do 
so, we tested the levels of PINCH and α-parvin which, together with ILK, form a stable ternary 
complex at the cell-ECM adhesion sites (Tu et al., 2001b; Tu et al., 1999a; Wu, 2004b; Zhang et 
al., 2002b; Zhang, 2002).   
 
ILK-floxed hepatocytes that were infected with Cre-adenovirus and had reduced levels of 
ILK (Fig.31A), also showed a dramatic reduction in both PINCH (Fig.31B) and α-parvin protein 
expression levels (Fig.31C).  Interestingly, the level of Mitogen-inducible gene-2 (Mig-2), 
another cell-matrix adhesion protein closely associated with ILK (Mackinnon et al., 2002a; Tu et 
al., 2003b), was not altered after the removal of ILK from hepatocytes (Fig. 31D).   
 
 
Figure 31: Changes in the expression level of other proteins as a result of removal of ILK from 
ILK-floxed mouse hepatocytes. Western blot analysis for A)ILK, B)PINCH, C) α-parvin, D)Mig-2, 
E)phosphor-Akt (Ser473), 5 days post infection with either β-gal or Cre-adenovirus. 
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The phosphorylation of PKB/Akt is not affected by the loss of ILK from hepatocytes 
Previous studies have shown that inhibition of either ILK, PINCH, or α-parvin induces 
extensive apoptosis in HeLa cells, and that the activation of PKB/Akt, a key regulator of cell 
survival, is also impaired (Fukuda et al., 2003a; Fukuda et al., 2003b).  In order to test whether 
depletion of ILK from primary hepatocytes leads to apoptosis through the PKB/Akt pathway, we 
examined the expression level of phosphorylated-Akt at Ser473, the phosphorylation site that 
activates Akt (Fukuda et al., 2003a; Fukuda et al., 2003b; Troussard et al., 2003b).  As shown in 
Fig.31E, the level of phosphorylated Akt at Ser473 does not change after removal of ILK. 
 
ILK protein is significantly reduced in animals injected with Cre-adenovirus, in vivo 
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To gain further knowledge on the significance of ILK for hepatocytes, we employed an in 
vivo approach.  PBS, β-gal or Cre-adenovirus were delivered into ILK-floxed animals via the tail 
vein, which has been shown to be an effective way of administrating adenovirus in the liver in a 
homogeneous fashion with high reproducibility of expression (Herrmann, 2004).  Injections were 
performed in 78 ILK-floxed mice 
(19-31 weeks old), and mice were 
sacrificed two, four, five, seven, 
eight or ten days later.   
 
Figure 32: Elimination of ILK 
from the mouse liver by 
administration of Cre-recombinase 
expressing adenovirus via tail vein. 
A) Western blot showing the 
expression level of ILK in samples 
from ILK-floxed mouse livers 
injected with either β-gal or Cre 
adenovirus (Day 5 and 10 post-
injection) using anti-ILK antibody. 
Equal loading was confirmed by 
actin reprobing of the same 
membrane. B) PCR using primers 
that detect the presence of Cre gene 
(arrow).  Note that only the Cre-
injected animals have the Cre gene 
(compare lanes 2 and 3 to 4 and 5).  
 
As shown in Fig.32A the ILK protein level was reduced in the Cre-adenovirus-injected 
animals compared to the β-gal adenovirus injected animals in all animals injected with Cre-
adenovirus at all the time points tested.  This corresponds with specific expression of Cre 
recombinase in the Cre adenovirus injected mice (Fig.32B, compare lanes 2 and 3 to lanes 4 and 
5.  The band that corresponds to the Cre gene is shown with an arrow). 
Figure 33: Gross appearance 
and H&E staining of the livers 
from β-gal or Cre-injected 
animals 
A) Gross appearance of the liver 
of a control β-gal-adenovirus-
injected mouse, B) Gross 
appearance of the liver of a 
mouse injected with Cre-
recombinase expressing 
adenovirus, C) H&E staining on 
frozen liver sections taken from a 
β-gal-adenovirus-injected mouse, 
D) H&E staining on frozen liver 
sections taken from a Cre-
adenovirus-injected mouse. 
Arrows point to apoptotic cells, 
E) H&E staining on formalin-
fixed, paraffin embedded sections 
from a β-gal-adenovirus-injected 
mouse liver, F) H&E staining on 
formalin-fixed, paraffin 
embedded sections from a Cre-
adenovirus-injected mouse liver.  
Arrows point to apoptotic cells, 
while arrowheads show necrotic 
cells with ballooning 
degeneration. G) TUNEL 
staining on formalin-fixed, 
paraffin embedded sections from 
a β-gal-adenovirus-injected 
mouse liver, H) TUNEL staining 
on formalin-fixed, paraffin 
embedded sections from a Cre-
adenovirus-injected mouse liver 
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Livers from the animals injected with Cre adenovirus are significantly impaired and show 
signs of hepatitis 
ILK floxed mice were sacrificed at two, four, five, seven, eight, or ten days after injection 
with either β-gal or Cre-adenovirus, and liver histology was examined.  Livers were further 
analyzed by PCR and immunoblotting.  The gross appearance of the livers from most of the Cre-
adenovirus injected animals (35 out of 45) was greatly altered.  Livers were larger, with a coarse 
granular surface and very pale, compared with control livers from β-gal adenovirus injected mice 
(Fig.33, compare A and B).  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34: Statistical analysis of the differences in the histology between β-gal and Cre-adenovirus-
injected ILK-floxed mouse livers. The bar graph shows the differences in the liver histology scores 
between β-gal control and Cre-adenovirus-injected ILK-floxed animals, at different time points after 
injection.  The day of injections is considered as day 0.  The statistical analysis was conducted using the 
Mann-Whitney test and the Statgraphics Plus statistics software.  A p value of less that 0.05 was 
considered as statistical significant. 
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At the microscopic level, the liver histology exhibited a variety of abnormal 
characteristics and it was blindly scored on a scale of 0 to 5 (experimental procedures section).  
The highest score (five) was attributed to livers with the worst histology, exhibiting 
inflammation, and/or fatty change, apoptosis, ballooning degeneration, abnormal mitoses, 
hydropic degeneration, and necrosis.  Collectively, 85% (23 out of 27) of the β-gal-adenovirus 
injected animals had normal livers (score 0-1) whereas the remaining 15% exhibited signs of 
mild inflammation and had a few apoptotic cells (score 2).  In the Cre adenovirus-injected 
animals, 78% (35 out of 45) had abnormal liver histology (score 3-5), while 22% appeared to 
have relatively normal histology (score 1-2).  That can be attributed to problems with the tail 
vein administration of the virus which resulted in the actual delivery of only a portion of the 
intended amount of virus in some of the animals.  The Cre-adenovirus-injected animals, at each 
one of the time points tested, had more severe pathology and thus higher scores than the control 
β-gal-injected ones and the difference was statistically significant as shown by Mann-Whitney 
test (p<0.05) (Fig.34).   
 
Interestingly, three animals from the Cre-injected group died 2, 4 and 5 days after being 
injected and their livers showed the most severe pathology.  Representative images of the 
histology of the control and Cre-adenovirus-injected animals are shown in Fig.33 (compare C 
and E to D and F).  Finally, confirming the apoptosis observed from the H&E staining, the livers 
of the Cre-adenovirus-injected animals exhibited dramatically increased TUNEL staining 
(Fig.33, compare G and H).  
 
Lastly, to determine whether genetic susceptibility to Cre recombinase toxicity played a 
role in the results that we obtained, eight wild type mice of the strains 129X1/SvJ and C57BL/6J 
(the background of the ILK-floxed mice) were injected with Cre adenovirus using the same exact 
titer as the one utilized in the ILK-floxed animals.  Wild type livers were normal, both 
macroscopically and microscopically.  This indicates that the severe phenotype observed in the 
Cre-injected animals was a response to loss of ILK and not a side effect of the Cre-adenovirus. 
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6.4 DISCUSSION 
Hepatocytes are the parenchymal cells of the liver and thus, they perform a number of 
complicated functions to maintain homeostasis.  Of particular importance for normal hepatocyte 
function, both in vivo and in vitro, is the surrounding matrix (Block et al., 1996b; Kumaran et al., 
2005; Michalopoulos et al., 1999; Ohashi and Kay, 2004).   
 
ILK is a cell-ECM adhesion protein that mediates signal transduction between integrins, 
ECM, and the interior of cells.  It directly interacts with PINCH and α-parvin and, together they 
form a stable ternary complex at the cell-ECM adhesion sites.  In fact these proteins are pre-
assembled in a ternary complex and the entire complex is then localized to the cell-ECM sites 
(Zhang et al., 2002b). ILK, as well as PINCH and α-parvin are widely expressed in the human 
tissues and well-conserved among different species (Clark et al., 2003; Mackinnon et al., 2002a; 
Wu and Dedhar, 2001b).  As such, it is not surprising that ILK is critically involved in many 
fundamental cellular processes (Hannigan et al., 2005; Legate et al., 2006; Wu, 2005). 
 
In the present study, we investigated the role of ILK in mouse hepatocytes by specifically 
eliminating it in vitro from primary hepatocytes in culture and in vivo from the whole liver.  In 
vitro, the ILK-depleted cells underwent dramatic apoptosis, as assessed by morphological 
changes and caspase 3 activity measurements.  Interestingly, re-introduction of ILK substantially 
reversed the effect on apoptosis suggesting that apoptosis is indeed due to the removal of the ILK 
and that the protein itself helps prevent cell death.   
 
Cells lacking ILK also display reduced levels of PINCH and α-parvin, while Mig-2, 
another ILK-binding protein, is not affected.  The reduction in the level of PINCH, and α-parvin 
following ILK-depletion has been shown previously in other cell types (Fukuda et al., 2003a; 
Fukuda et al., 2003b), while both PINCH and α-parvin have been implicated in cell survival 
(Fukuda et al., 2003a; Fukuda et al., 2003b).  Therefore reduction of their level could contribute 
to or enhance the apoptosis induced by the decreased level of ILK.  Hence, in cultured primary 
hepatocytes, the components of the PINCH-ILK-parvin complex appear to function in concert to 
mediate cellular signaling for survival.  
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 Mig-2 is a cell-ECM adhesion protein closely associated with the PINCH-ILK-parvin 
complex and integrin signaling and has been shown to regulate cell shape and spreading (Legate 
et al., 2006; Tu et al., 2003b; Wu, 2005).  Mig-2 level does not change following ILK removal 
from hepatocytes, which indicates that not all the cell-matrix adhesion proteins are affected by 
the depletion of ILK, but rather the two proteins that form the ternary complex with ILK are the 
ones that are most dramatically affected.    
 
Several studies in cancer cell lines or immortalized cells, have shown that ILK regulates 
survival through the PKB/Akt pathway (Delcommenne et al., 1998b; Fukuda et al., 2003a; 
Persad et al., 2000a; Persad et al., 2001; Troussard et al., 2003b).  In this study, we tested the 
expression level of active-phosphorylated-Akt (Ser473) following depletion of ILK from primary 
hepatocytes and found that it was not affected (Fig.5B), indicating that ILK regulates primary 
hepatocyte survival through a pathway other than the PKB/Akt.  Our finding is in accordance 
with other studies using ILK deficient fibroblasts (Legate et al., 2006; Sakai et al., 2003) that 
also showed no alterations in the phosphorylation status of Akt.  The reason for the discrepancy 
is unclear but may be attributed to either cell-type specific differences or possibly differences in 
the mechanisms that are activated in primary cells versus immortalized and/or cancerous cell 
lines. 
 
Consistent with our in vitro data, in vivo elimination of ILK from ILK-floxed mice, 
resulted in severe liver abnormalities ranging from inflammation, apoptosis, and fatty change to 
acute, full-scale hepatitis.  The finding that the liver was the most obviously affected organ by 
the ILK elimination is explained by the fact that administration of Cre-adenovirus through the 
tail vein leads to higher infectivity of the adenovirus with higher recombination levels in the liver 
and spleen, as opposed to other organs (Wang, 1996).   
 
Furthermore, it is worth noting that the adenoviral injection itself caused some 
inflammation as shown by the results of the β-gal-injected animals, 15% of which show signs of 
inflammation and small scale apoptosis. This is consistent with previous studies demonstrating 
toxicity effects of adenovirus vectors in hepatocytes(Shayakhmetov, 2004).  
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 Altogether, our results clearly show that elimination of integrin signaling by removal of 
ILK is detrimental to primary hepatocyte survival in culture, as well as to the function of the 
whole liver.  Thus, ILK is of great importance for the liver in general, consistent with recent 
work by Shafiei et al. highlighting the importance of ILK in liver wound healing (Shafiei, 2006).  
Nevertheless, more research is needed in order to decipher the exact mechanisms involved.  
Understanding the mechanisms that regulate survival in hepatocytes in vitro and in vivo is of 
utmost importance since the balance between cell survival and death is delicate and can be easily 
disrupted in cases of liver injury. 
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7.0  TARGETED GENETIC ELIMINATION OF ILK IN THE LIVER LEADS TO 
ABNORMAL LIVER ARCHITECTURE AND BILIARY MALFORMATIONS 
7.1 INTRODUCTION 
The liver is the biochemical factory of the body performing numerous functions at the same time 
and it is thus essential for the normal function of the whole body.  It consists of hepatocytes, the 
parenchymal cells of the liver, as well as the non-parenchymal cells which include the 
endothelial cells, the stellate cells, the Kupffer cells and the biliar cells(Michalopoulos and 
DeFrances, 2005).  In order for all those cells to function properly, the interaction with the 
extracellular matrix (ECM) is of utmost importance.  
 
In fact, how essential ECM is for normal liver function is shown by the fact that the liver 
is undergoing matrix breakdown and remodeling at the earliest stages of regeneration after 
partial hepatectomy (Kim et al., 2000; Kim et al., 1997; Michalopoulos and DeFrances, 2005; 
Michalopoulos and DeFrances, 1997).  Moreover, hepatocytes are greatly depended on the ECM 
for their differentiation.  Hepatocytes in culture rapidly lose expression of their differentiation 
markers when maintained in the absence of matrix but differentiation and normal hepatocyte 
architecture is quickly restored upon addition of complex matrix environments (e.g. Matrigel, or 
collagen gels)(Block et al., 1996b; Bucher, 1990; Kim et al., 1998).  Finally, the importance of 
ECM for liver is again demonstrated in cases such as cirrhosis, where alterations of liver matrix 
affect hepatocyte growth and differentiation. 
 
 The communication between cells and the ECM is achieved through integrins and 
the associated integrin-proximal adhesion molecules(Hynes, 2002).  Through multiple protein-
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protein interactions and signaling events, these molecules transmit signals from the ECM to the 
inside of the cell and regulate many fundamental cellular processes. 
 Integrin-Linked Kinase (ILK) is a β1- and β3-integrin-interacting cell matrix 
adhesion protein that has been proven to be crucial for a number of cellular processes such as 
survival, differentiation, proliferation, migration, and angiogenesis(Huang et al., 2000; Legate et 
al., 2006; Li et al., 2003; Wu, 2001a; Wu, 2004b), while there is strong evidence that 
overexpression of ILK leads to oncogenic transformation with all the accompanied attributes 
(Persad and Dedhar, 2003; Radeva et al., 1997; Troussard et al., 2000). 
 
 Despite massive evidence that ECM signaling affects hepatocyte structure and function, 
the impact of this at the level of the whole organ has not been assessed at a genetic level and the 
role of ILK in the liver has not been investigated either.  
 
In the present work, in order to study the contribution of ILK in the biology and function 
of the liver, we used the genetic mouse model of targeted elimination of a gene in a specific 
organ by the LoxP-Cre system and we eliminated ILK from the mouse liver.   
 
To do that we crossbred ILK-floxed animals (Terpstra et al., 2003) with three strains of 
transgenic animals that express Cre-recombinase under the control of promoters related to 
hepatocyte-associated transcription factors and genes; the albumin promoter, Alpha Fetoprotein 
(AFP) enhancer-albumin promoter, and Foxa3-promoter. The albumin promoter and AFP-
enhancer-albumin-promoter are turned on after liver specification. Albumin expression, even 
though present during liver embryonic development, becomes stronger after birth whereas AFP 
expression is stronger during embryonic life and declines after birth.  Previous studies have 
shown that although albumin is expressed early in development, the Cre-recombinase under an 
albumin promoter can completely ablate a floxed gene from the liver at about 6 weeks of age, 
while the recombination is not complete at earlier stages after birth(Postic and Magnuson, 2000).  
 
 Thus, in the present work, most of our studies were done in 8 week old mice.  Regarding 
the Cre-recombinase expressed under the control of an AFP-enhancer-albumin-promoter, it is 
known that it allows position-independent expression of Cre-recombinase in mice at the same 
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time at which the endogenous albumin gene gets activated during embryoegesis(Kellendonk, 
2000; Tronche, 1999).  Finally, the Cre-recombinase expressed under the Foxa3 promoter, also 
known as HNF3 gamma, is expressed in the ventral endoderm just prior to hepatic 
specification(Lee, 2005).   
 
Cre-recombinase expression under the three different promoters allows assessment of 
ILK ablation at different stages (from the very earliest stages in liver development to a few 
weeks after birth), and thus provides us with a more complete picture of the role of ILK in the 
liver. 
7.2 MATERIALS AND METHODS 
Antibodies 
The following primary antibodies were used in this study: mouse monoclonal (mAb) anti-ILK 
antibody (clone 69) (Santa Cruz biotechnology, Santa Cruz, CA), PCNA, Ki67, and anti-β-actin 
mAb (Chemicon, Temecula, CA).  Goat-anti-mouse secondary Abs was purchased from Jackson 
ImmunoResearch Laboratories (West Grove, PA).  
 
Animals 
The ILK-floxed animals that were used in the present study were generated as described 
previously(Troussard et al., 2003c).  The ILK-floxed mice were crossbred with three strains of 
mice expressing Cre-recombinase under the control of promoters related to hepatocyte-
associated transcription factors and genes; the albumin promoter, AFP-enhancer-albumin 
promoter, and Foxa3-promoter.  The AFP-enhancer-albumin promoter and the Foxa3-promoter 
Cre expressing mouse strains were kindly provided by Dr. Klaus Kaestner (University of 
Pennsylvania), while the albumin-promoter Cre-expressing mice were purchased from Jackson’s 
laboratories.  All animals were housed in the animal facility of the University of Pittsburgh and 
all experiments were performed under protocols approved by the Institutional Animal Care and 
Use Committee (IACUC) of the University of Pittsburgh.  Animals were treated humanely 
according to the criteria outlined in the “Guide for the Care and Use of Laboratory Animals” 
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prepared by the National Academy of Sciences and published by the National Institutes of 
Health.   
 
Liver-specific inactivation of the ILK gene 
The ILK-floxed mice were mated with mice from three strains of mice expressing Cre-
recombinase under the control of hepatocyte-specific promoters; the albumin promoter, Alpha 
Fetoprotein (AFP) enhancer-albumin promoter, and Foxa3-promoter.  Genotyping was 
performed by PCR from DNA isolated from the mice tails using previously published primer 
sequences(Troussard et al., 2003c).   
 
Liver perfusion with collagenase and separation of hepatocytes from non-parenchymal cells of 
the liver 
Mouse hepatocytes from the AFP-albumin-ILK-knock-out animals, albumin-ILK-knock-out 
animals or Foxa3-ILK-knock-out animals, as well as their respective controls, were isolated by 
an adaptation of the calcium two step collagenase perfusion technique, as described 
previously(Block et al., 1996a).  Following the liver perfusion, hepatocytes were separated from 
the non-parenchymal cells of the liver by several centrifugation steps.  
 
Briefly, the cell pellet obtained from the liver perfusion was centrifuged at 500 rpm for 
5min and the supernatant was saved.  The pellet was subsequently washed with Hanks HBSS 
buffer and centrifuged at 500rpm for 5min, and the supernatant was again saved for later use 
while the pellet was kept as the fraction that corresponds to hepatocytes.  The supernatants from 
the last two centrifugations were combined and centrifuged at 600 rpm for 5min.  The resulting 
supernatants were then centrifuged at 1,500 rpm for 5min and the pellet was saved and washed 
once again with HBSS buffer.  This pellet contained all the non-parenchymal cells of the liver 
(stellate cells, endothelial cells, Kupffer cells, biliar cells). 
 
Immunohistochemistry 
Immunohistochemical staining of formalin-fixed, paraffin-embedded liver sections was 
performed as described previously. 
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Protein isolation for immunoblotting 
Total protein was isolated from the mouse hepatocytes, non-parenchymal cells of the liver or 
whole livers from the AFP-albumin-ILK-knock-out, albumin-ILK-knock-out or Foxa3-ILK-
knock-out animals using 1% sodium dodecyl sulfate (SDS) in RIPA buffer (20 mM Tris/Cl  pH 
7.5, 150 mM NaCl, 0.5% NP-40, 1% TX-100, 0.25% Sodium Deoxycholated (DOC), 0.6-2 
µg/ml aprotinin, 10µM Leupeptin, 1µM Pepstatin).   
 
Light and Transmission Electron Microscopy 
Mouse livers were perfusion-fixed through the heart with 2.5% glutaraldehyde in PBS.  Liver 
was removed and immersed in the same fixative for 2 additional days at 4oC.  Several 1mm3 
cubes were removed from the liver, were washed 3 times in PBS and were then post-fixed in 
aqueous 1% OsO4, 1% K3Fe(CN)6 for 1 hour.  Following 3 PBS washes, the pellet was 
dehydrated through a graded series of 30-100% ethanol, 100% propylene oxide then infiltrated in 
1:1 mixture of propylene oxide: Polybed 812 epoxy resin (Polysciences, Warrington, PA) for 1 
hr.  After several changes of 100% resin over 24 hrs, the pellet was embedded in molds, cured at 
37oC overnight, followed by additional hardening at 65oC for two more days.  Ultra thin (60 nm) 
sections were collected on copper grids, stained with 2% uranyl acetate in 50% methanol for 10 
minutes, followed by 1% lead citrate for 7 min.  Sections were on a JEOL JEM 1210 
transmission electron microscope (Peabody, MA) at 80 kV using am AMT 2K digital camera 
(Advanced Microscopy Technologies, Danvers MA).   
 
TUNEL assay 
Apoptosis in livers from the AFP-albumin-ILK-knock-out, albumin-ILK-knock-out or Foxa3-
ILK-knock-out animals was assessed by terminal deoxynucleotidyltransferase-mediated dUTP-
biotin nick end-labeling (TUNEL) assay using the ApopTag In Situ Apoptosis Detection Kit 
from Chemicon (Temecula, CA).  
 
Microarray analysis  
cRNA preparation: Total RNA was extracted and purified with Qiagen RNeasy kit (Qiagen, 
San Diego, CA) from whole livers harvested from 8-week-old AFP-albumin-ILK-knock-out, 
albumin-ILK-knock-out or Foxa3-ILK-knock-out animals and their respective controls.  Five 
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micrograms of total RNA were used in the first strand cDNA synthesis with T7-d(T)24 primer 
(GGC CAG TGA ATT GTA ATA CGA CTC ACT ATA GGG AGG CGG-(dT)24) by 
SuperscriptTM II (GIBCO-BRL, Rockville, MD).  The second strand cDNA synthesis was carried 
out at 16oC by adding E. coli DNA ligase, E. coli DNA polymerase I and RnaseH in the reaction.  
This was followed by the addition of T4 DNA polymerase to blunt the ends of newly synthesized 
cDNA. The cDNA was purified through phenol/chloroform and ethanol precipitation.  The 
purified cDNA were then incubated at 37oC for 4 hours in an in vitro transcription reaction to 
produce cRNA labeled with biotin using MEGAscriptTM system (Ambion, Inc, Austin, TX).  
 
Affymetrix chip hybridization: Fifteen to 20 µg of cRNA were fragmented by incubation in a 
buffer containing 200 mM Tris-acetate, pH 8.1, 500 mM KOAc, 150 mM MgOAc at 95oC for 35 
minutes.  The fragmented cRNA were then hybridized with a pre-equilibrated Affymetrix chip 
(R430 2.0) at 45oC for 14-16 hours.  After the hybridization cocktails were removed, the chips 
were then washed in a fluidic station with low-stringency buffer (6x SSPE, 0.01% Tween 20, 
0.005% antifoam) for 10 cycles (2 mixes/cycle) and stringent buffer (100 mM MES, 0.1 M NaCl 
and 0.01% Tween 20) for 4 cycles (15 mixes/cycle), and stained with SAPE (Strepto-avidin 
Phycoerythrin).  This was followed by incubation with biotinylated mouse anti-avidin antibody, 
and restained with SAPE.    
 
The chips were scanned in a HP ChipScanner (Affymetrix Inc, Santa Clara, CA) to detect 
hybridization signals. For quality assurance, all samples were run on Affymetrix test-3 chips to 
evaluate the integrity of RNA.  Samples with RNA 3’/5’ ratios less than 2.5 were accepted for 
further analysis. 
7.3 RESULTS 
ILK elimination during embryonic development does not affect hepatic embryonic growth 
To study the effects of ablation of ILK in vivo, we mated the ILK floxed animals with mice 
expressing Cre-recombinase under three promoters related to hepatocyte-associated transcription 
factors and genes; AFP-enhancer albumin promoter, albumin promoter or Foxa3 promoter.  
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DNA from mouse tails from the resulting offspring was used for genotyping the mice.  The mice 
that had a copy of the Cre gene and were homozygous for the floxed-ILK gene were considered 
to be conditional knock-out animals.   
 
Mice were sacrificed at different time points after birth and their livers were harvested.  
More specifically, livers were collected starting as early as 1 day after birth, at 14 days, 5 weeks, 
8-10 weeks, and 30-39 weeks of age.   
 
Although the complete ILK knock-out is embryonic lethal at the pre-implantation stage, 
suggesting that ILK is indispensable for normal development, all three types of the ILK 
conditional knock-out mice in the liver are born normal with normal liver histology, which at 
birth is indistinguishable between the knock-out and the control WT mice.   
 
This suggests that ILK is most likely not essential for the liver development.  Soon after 
birth, though, the growth of the Foxa3-Cre ILK knock-out mice becomes stunted and the mice at 
2 weeks of age are about have the size of their normal litter-mates.  This phenomenon however is 
not true for the albumin-ILK-knock-outs or the AFP-albumin-ILK knock-outs, which appear 
normal in size. 
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Figure 35: ILK expression level is dramatically reduced in the liver of the conditional 
knock-out animals and the reduction is due to elimination of the ILK from the hepatocytes A) 
Western blotting analysis with an anti-ILK monoclonal antibody performed on total cell lysates extracted 
from whole livers from the AFP-albumin-Cre, albumin-Cre and Foxa3-Cre conditional knock-out 
animals.  β-actin is used as loading control.  The last lane corresponds to a wild type animal (WT).  B) 
Bar graph showing the ILK expression level in whole liver, isolated non-parenchymal cells (solid white 
bars) and isolated hepatocytes (solid black bars) from the control and AFP-albumin-Cre-ILK-knock-out 
animals.  C) Bar graph showing the ILK expression level in whole liver, isolated non-parenchymal cells 
(solid white bars) and isolated hepatocytes (solid black bars) from the control and albumin-Cre-ILK-
knock-out animals.  D) Bar graph showing the ILK expression level in whole liver, isolated non-
parenchymal cells (solid white bars) and isolated hepatocytes (solid black bars) from the control and 
Foxa3-Cre-ILK-knock-out animals. 
 
 
ILK is removed from the liver of the conditional knock out animals 
In order to find out whether ILK was indeed removed from those animals, we performed 
western blot analysis with anti-ILK antibody in whole cell lysates isolated from whole liver.  As 
shown in Figure 35A, ILK was efficiently knocked down in AFP-albumin-ILK-knock-out, 
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albumin-ILK-knock-out and Foxa3-ILK-knock-out animals.  However, there was still a certain 
amount of ILK remaining in the knock-out animals (see Fig.35A).   
 
ILK is removed from the hepatocytes and not the non-parenchymal cells of the liver 
Thus, we next sought to find which population of liver cells the ILK was removed from.  
To do that we performed a liver perfusion and subsequently we separated the hepatocytes from 
the non-parenchymal cells.  As shown in Fig.35B-D, ILK expression level is almost the same 
between the control and the conditional knock-outs in the non-parenchymal cells of the AFP-
albumin and Foxa3 ILK conditional knock-outs, while it is dramatically reduced in the 
hepatocyte fraction of the same mice (compare the 2 white bars with the 2 black bars in Fig.35B-
D).   
 
This suggests that ILK is indeed removed from the hepatocytes but not the non-
parenchymal cells of the liver (endothelial cells, Kupffer cells, stellate cells and biliar cells), 
explaining why a significant amount of ILK is still present in whole cell lysates from the liver 
tissue of the conditional knock-out animals (Fig.35A, and Fig. 35B-D, stripped bars).  
 
 
The ILK conditional knock-out animals exhibit abnormal liver architecture, apoptosis, and 
biliar malformations 
As mentioned above, the liver phenotype of the 1-day old ILK-conditional knock-outs in 
the liver was normal (data not shown) but as the mice progressed in age their livers exhibited 
severe abnormalities as compared to the control animals.  Macroscopically, while the rest of the 
organs appeared normal the livers from the ILK conditional knock-outs were paler and their 
texture was extremely hard.   
 
The abnormalities were confirmed in the microscopic level as well.  At the stage of 4 
weeks, hepatocytes in all three categories of knock-out mice are not organized in standard (one 
cell thick) hepatic plates, but they remain in disorganized clumps (Fig.36, compare B to A, D to 
C, and F and G to E).  
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Figure 36: H&E staining from the ILK-conditional knock-out animals in the liver shows dramatic 
abnormalities H&E staining in the liver of: A, C and E) control WT animals, B) AFP-albumin-ILK 
knock-out animals, D) albumin-ILK knock-out animals, F and G) Foxa3-ILK knock-out animals. 
 
 
 
 More importantly, there is diffuse hepatocyte apoptosis, associated with compensatory 
proliferation and apparent infiltration by inflammatory cells.  Finally, livers develop fibrosis akin 
to cirrhosis. 
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Interestingly, Foxa3 mice had the most severe phenotype and were completely lacking 
bile ducts in their portal triads (Fig. 36, compare F and G to E), whereas the other two categories 
had bile ducts in about 1/3 of the portal triads.  
 
Thus, ablation of ILK from hepatocytes in vivo caused severe defects in hepatic tissue 
architecture, suggesting that ILK is essential for normal liver organization and the formation of 
the biliar tree. 
 
There is no dosage effect in heterozygous Cre+/- ILK fl/WT animals and there is no toxicity in 
the Cre+/- ILK WT/WT animals 
In order to test whether there was any toxicity effect associated with the observed 
apoptosis and inflammation in the conditional knock-out animals that could be attributed to the 
expression of one copy of the Cre-recombinase gene in these mice, we examined the liver 
histology of Cre 
positive mice that 
expressed non-floxed 
Wild Type (WT) ILK.  
As shown in Fig.37 A, 
C, and E, the livers 
from those animals 
were completely 
normal, excluding the 
possibility of Cre-
induced toxicity.   
 
Figure 37: H&E staining 
of liver sections from 
mice that are Cre+ and 
have WT ILK or Cre+ with one copy of the floxed ILK gene A, C, and E) H&E from the Cre+ 
ILKWT mice livers, B, D and F) H&E from the Cre+ ILK Fl/WT livers. 
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We next examined whether there was an abnormal phenotype in Cre-positive mice that 
only had one copy of the floxed ILK gene and one of the WT (ILKfl/WT).  No abnormalities 
were observed in the liver of these ILK heterozygous Cre-positive animals (Fig.37, B, D and F), 
suggesting that expression of only one allele of the ILK gene is enough for the livers to be 
normal, and thus there is no dosage effect. 
 
Abnormal ultra-structure of the cell-cell junctions in the conditional knock out animals 
In order to better characterize the phenotype observed in the ILK-conditional knock-out 
animals in the liver, we performed a light and transmission electron microscopy (TEM) study on 
perfusion-fixed 8-week-old male mice.  Interestingly, TEM images show presence of blunted 
microvilli or complete absence of microvilli from the bile canaliculi (Fig. 38), while the 
junctional complexes are also compromised.  It seems that only tight junctions are present along 
the canaliculi and not gap junctions or desmosomes (Fig.38).  Moreover, all the livers from the 
conditional knock-out mice have excessive collagen deposition (Fig.38), which explains the hard 
texture of those livers. 
 
Figure 38: Transmission 
Electron Microscopic 
(TEM) analysis of livers 
from the ILK-conditional 
knock-out animals. A) 
TEM image from the liver 
of a control animal where 
the microvilli of the 
canaliculus are visible, B) 
TEM image from an ILK 
knock-out animal where 
there is absence of 
microvilli, C) TEM image 
from an ILK knock-out 
animal where there is 
evident excessive collagen 
deposition. 
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Increased apoptosis in all the ILK- conditional knock-out animals in the liver 
Since ILK is known to be involved in regulating cell survival(Attwell et al., 2000a; 
Persad et al., 2000a), it would be anticipated that elimination of the protein would likely result in 
cell death.  To test whether this is true in vivo as well following genetic removal of ILK from the 
liver, we performed TUNEL staining in formalin-fixed paraffin-embedded liver sections from 8 
week-old female mice.  Consistent with the apoptotic cells observed by H&E staining, the 
control livers were negative for TUNEL staining, but the livers from the ILK-conditional knock-
out mice had many TUNEL-positive hepatocytes (Fig.39), indicating that there is an ongoing 
apoptosis in these animals. 
 
 
 
Figure 39: TUNEL staining shows increased apoptosis in the livers of the ILK conditional-knock-
out animals. TUNEL staining in liver sections of: A)control WT animal, B) AFP-albumin-Cre-ILK-
knock-out animal, C) albumin-Cre-ILK-knock-out animal, D) Foxa3-Cre-ILK-knock-out animal. 
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Increased proliferation in all the ILK conditional knock-outs in the liver 
Cases of increased apoptosis in liver are often associated with increased proliferation, 
which is a compensatory mechanism associated with liver regeneration(Michalopoulos and 
DeFrances, 1997).  Thus, we also monitored cell proliferation by immunohistochemistry for two 
cell cycle markers; Proliferating Cell Nuclear Antigen (PCNA), a marker for cells in all stages of 
cell cycle, and Ki67, a marker for cells in the DNA synthesis phase (Data not shown).  As shown 
in Fig.40, all three types of liver ILK-conditional knock-outs exhibited significantly increased 
PCNA (Fig.40, compare B, C and D to panel A) and Ki 67 staining (Data not shown), suggesting 
that hepatocytes are undergoing cell proliferation.  Interestingly, the number of actual mitoses is 
also dramatically increased in the ILK-conditional knock-out animals compared to the controls 
(Fig.40E).  
 
Figure 40: Increased proliferation in the livers of the ILK conditional-knock-out animals.  A-D) 
PCNA staining in livers from control animals (A), AFP-albumin-ILK-knock-out animals (B), albumin-
ILK-knock-out animals (C), Foxa3-ILK-knock-out animals (D), E) bar graph showing the number of 
mitoses in the livers of control and conditional knock-out animals as observed in 10 different fields under 
the 40x, F-I) Ki 67 staining in livers from control animals (F), AFP-albumin-ILK-knock-out animals (G), 
albumin-ILK-knock-out animals (H), Foxa3-ILK-knock-out animals (I). 
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Microarray data analysis 
Finally, in order to shed more light upon the mechanism involved in the liver changes 
observed in the animals that lack ILK from their hepatocytes, we performed a GeneChip 
Microarray analysis in 8-week old AFP-albumin-ILK-knock-out, albumin-ILK-knock-out and 
Foxa3-ILK-knock-out animals.  The data from the microarray analysis are summarized in 
separate gene categories in Tables 1-11.  In all three types of ILK-conditional knock-outs, the 
same genes were significantly up- or down-regulated, suggesting that the removal of ILK is 
responsible for these changes.   
 
In brief, there seems to be an increase in almost all integrin genes (Table 1) possibly in 
order to compensate for the lost signal from the matrix due to the removal of the ILK.  At the 
same time, there is a significant upregulation in all the types of procollagen genes (Table 2), 
which explains why there is excessive deposition of collagen in the electron microscopic images 
(Figure 38C).  More striking was the fact that in all three conditional knock-outs, there was an 
across the board decrease of many differentiation-related markers, especially in the cytochrome 
P450 family members (Table 3) indicating a decrease in differentiation.  Interestingly, increased 
expression of the mRNA levels of several apoptosis-related genes such as annexins, Bax, Bad, 
PUMA, TNF (Table 6) supports our previous data showing apoptosis in the livers of the 
conditional knock-out animals (Figure 39).  Furthermore, an interesting change in several growth 
factors (Table 4), transcription factors (Table 5), signaling proteins (Table 7), several classes of 
proteases (Table 9), cell adhesion proteins (Table 10) and cell cycle proteins (Table 11), 
underlines the complexity of the signaling events triggered by the removal of ILK signaling and 
the importance of that for the normal liver function and homeostasis. 
7.4 DISCUSSION 
Cell-ECM adhesions are of utmost importance for the normal signal transduction between the 
environment and the cells within a tissue.  Liver is a good example of an organ that is greatly 
dependent on the ECM, deregulations of which can give rise to serious diseases such as cirrhosis.   
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In the present study, we utilized the LoxP-Cre system(Kos, 2004) to eliminate ILK from 
mice at different stages of their development/life by mating the ILK-floxed animals with one of 
three Cre-expressing strains of mice; AFP-albumin-Cre, albumin-Cre or Foxa3-Cre mice. 
 
Our results show that ILK was indeed removed from the animals and in fact it was 
specifically removed from hepatocytes and not the non-parenchymal cells of the liver.  Although 
the anti-ILK antibody worked nicely for western blotting analyses, we encountered great 
difficulties in immunohistochemical studies with all the commercially available anti-ILK 
antibodies that we tried.   
 
Interestingly, there was never a doubt about the phenotype of the ILK conditional-knock-
out animals.  All three types of ILK conditional knock-out in the liver had abnormal liver 
architecture, evident apoptosis, compensatory proliferation and different degrees of biliar 
malformations with the Foxa3-ILK-knock-out mice having complete absence of bile ducts.  
Moreover, the abnormally formed or completely absent microvilli in the canaliculi space and the 
abnormal junctional complexes as seen by electron microscopy further corroborate the idea that 
ILK is essential for normal liver architecture. 
 
The observed hepatocyte apoptosis is consistent with previous studies where inhibition of 
ILK results in apoptosis in cancer cell lines(Persad et al., 2000a), or overexpression of ILK 
inhibits anoikis(Attwell et al., 2000a).  In fact, as shown in Chapter 6, elimination of ILK from 
the ILK-floxed hepatocytes in vitro and in vivo by adenoviral delivery of Cre-recombinase gives 
rise to massive apoptosis in cultured cells and fulminant hepatitis in the whole animal.  The 
adenovirus-mediated elimination of ILK from hepatocytes represents a more acute response to 
the removal of ILK while the genetic elimination of ILK corresponds to a chronic response but 
with severe architectural abnormalities involved. 
 
Furthermore, the microarray analysis provided us with more insight into the mechanism 
governing the observed changes following elimination of ILK.  ILK removal is accompanied by 
a dramatic reduction in the mRNA levels of most members of the cytochrome P450 family 
(Table 1), indicating inhibited differentiation, while at the same time there is an up-regulation of 
 97 
integrins α4, α5, α6, αL, αX, β1, β2 and β5, suggesting an attempt to compensate for the loss of 
ILK signaling by elevating the level of integrins and matrix-related genes (Table 3).  Overall, the 
microarray analysis provided us with explanations as to why there is such a phenotype in the 
mice, although it also generated a lot of questions that need to be addressed in the future 
regarding the pathways that are being activated or blocked upon ILK elimination. 
 
In conclusion, the dramatic changes seen with ablation of ILK demonstrate the 
importance of matrix signaling in hepatocytes and in the whole liver, and the important role of 
ILK for maintaining the normal liver architecture.   
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 Table 1.  Changes in the mRNA expression level of integrins in the ILK conditional knock-out 
animals. The number next to the name of the gene corresponds to the fold increase or decrease of the 
mRNA expression level of that gene in the ILK-conditional knock-out animal compared to the respective 
control animal.  
 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
integrin alpha 5   2.67 1.94 1.78 
integrin alpha 6 5.14 9.42 54.19 
integrin alpha 8 7.33 2.03 20.02 
integrin beta 1 1.89 1.63 1.85 
integrin beta 2 3.62 1.90 2.66 
integrin beta 5 2.58 1.84 2.46 
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Table 2. Changes in the mRNA expression level of ECM proteins in the ILK conditional knock-out 
animals. The number next to the name of the gene corresponds to the fold increase or decrease of the 
mRNA expression level of that gene in the ILK-conditional knock-out animal compared to the respective 
control animal.  
 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/-ILKfl/fl 
Foxa3-Cre+/-
ILKfl/fl 
Nidogen 1  15.17 14.69 35.62 
procollagen, type 
I, alpha 1 
14.34 9.73 2.86 
procollagen, type 
I, alpha 2 
14.97 6.29 12.97 
procollagen, type 
III, alpha 1 
17.28 4.16 7.90 
procollagen, type 
IV, alpha 1 
5.99 7.67 7.78 
procollagen, type 
IV, alpha 5 
2.41 4.24 4.35 
procollagen, type 
V, alpha 1 
5.81 2.08 8.01 
procollagen, type 
V, alpha 2   
8.63 2.63 5.95 
procollagen, type 
VI, alpha 1 
3.11 4.52 3.58 
procollagen, type 
VI, alpha 2 
2.49 4.88 21.08 
Vimentin 5.53 6.05 7.95 
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Table 3. Changes in liver-differentiation-related genes in the ILK conditional knock-out animals. 
The number next to the name of the gene corresponds to the fold increase or decrease of the mRNA 
expression level of that gene in the ILK-conditional knock-out animal compared to the respective control 
animal.  
 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/-ILKfl/fl 
Foxa3-Cre+/-
ILKfl/fl 
AFP 8.19 62.98 4.45 
cytochromeP450, 
CYP4F13 
0.46 0.89 0.33 
cytochrome P450, 17 0.11 0.97 0.10 
cytochrome P450, 1a2, 
aromatic compound 
inducible 
0.38 0.44 0.26 
cytochrome P450, 2c39 0.05 0.42 0.13 
cytochrome P450, 2c40 0.33 0.26 0.06 
cytochrome P450, 2d10 0.60 0.89 0.28 
cytochrome P450, 2g1 0.32 0.66 0.18 
cytochrome P450, 2j5 0.35 0.28 0.19 
cytochrome P450, 46 0.79 0.08 0.66 
cytochrome P450, 4a14 0.50 0.16 0.32 
cytochrome P450, 51 0.80 0.36 0.54 
cytochrome P450, 7b1 0.30 0.18 0.14 
cytochrome P450, CYP3A 0.01 0.12 0.02 
cytochrome P450, steroid 
inducible 3a41 
0.06 0.24 0.02 
cytochrome P450, 
subfamily IVF, 
polypeptide 14 
0.23 0.81 0.15 
H19 fetal liver mRNA 6.56 169.70 11.21 
hexokinase 1 1.58 2.39 10.93 
hexokinase 2 1.58 3.45 2.90 
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met proto-oncogene 3.08 0.57 0.97 
Serum amyloid A 2 6.42 7.85 1.87 
Villin - 30.3 7.52 
Villin 2 1.82 - - 
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Table 4. Changes in Growth Factor genes in the ILK conditional knock-out animals. The number 
next to the name of the gene corresponds to the fold increase or decrease of the mRNA expression level 
of that gene in the ILK-conditional knock-out animal compared to the respective control animal.  
 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
BDNF 1.70 0.10 34.18 
Bone 
morphogenetic 
protein 1 
0.79 0.89 0.57 
Bone 
morphogenetic 
protein 2 
0.77 0.47 0.85 
Bone 
morphogenetic 
protein 7 
0.72 0.27 0.86 
colony stimulating 
factor 1 
(macrophage) 
3.03 2.31 3.36 
EGFR 0.70 0.68 0.43 
FGF 1.97 1.64 7.94 
FGF-1 0.42 0.39 0.19 
FGF-4 0.74 1.33 2.75 
FGF-receptor 1 2.62 2.44 5.24 
FGF-receptor 2 1.89 1.65 2.15 
FGF-9 1.32 2.65 0.67 
FGF-21 2.43 0.74 2.63 
Growth 
differentiation 
factor 9 
2.03 0.84 0.87 
insulin-like growth 15.43 6.43 23.81 
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factor 2 
insulin-like growth 
factor 2 receptor 
1.99 0.75 3.43 
insulin-like growth 
factor 2, binding 
protein 3   
2.55` 15.54 3.64 
insulin-like growth 
factor binding 
protein 7 
4.06 2.07 3.39 
nerve growth 
factor, beta 
5.24 1.60 4.62 
PDGF alpha 1.68 3.64 3.21 
PDGF, polypeptide 
C 
3.07 2.69 5.32 
TGF alpha 1.32 1.62 1.91 
TGFb induced, 68 
kDa 
2.01 1.59 2.90 
TGF beta 1 2.60 2.06 3.85 
TGF-beta type I 
receptor  
1.36 1.82 2.23 
VEGF-A 0.53 0.50 0.23 
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Table 5. Changes in Transcription Factor genes in the ILK conditional knock-out animals. 
The number next to the name of the gene corresponds to the fold increase or decrease of the mRNA 
expression level of that gene in the ILK-conditional knock-out animal compared to the respective control 
animal.  
 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
adaptor protein 
complex AP-1, beta 
1 subunit 
2.08 1.33 0.70 
E2F transcription 
factor 1 
1.81 1.25 6.58 
Foxa3 1.31 1.57 0.85 
Foxp1 2.03 2.61 2.38 
Gut-enriched 
Kruppel-like factor 
GKLF 
0.81 0.34 2.16 
HIF-1alpha   0.60 0.78 6.86 
HNF1beta 28.47 1.66 2.17 
HNF-3forkhead 
homolog-4 (HFH-4) 
0.47 0.86 2.52 
HNF-4 1.39 0.80 1.20 
homeo box C9 
(Hoxc9) 
3.49 4.67 0.22 
Hoxa11 0.33 0.50 0.62 
Hoxa13 1.68 1.61 10.35 
homeobox 
transcription factor 
NKX2-3 
0.81 0.61 2.02 
Hoxa3 15.60 0.29 5.79 
Kruppel-like factor 5.00 1.58 6.10 
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7   
Kruppel-like factor 
15 
0.69 0.69 0.64 
Kruppel-like factor 
9 
0.56 0.61 0.38 
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Table 6. Changes in Apoptosis-related genes in the ILK conditional knock-out animals. The number 
next to the name of the gene corresponds to the fold increase or decrease of the mRNA expression level 
of that gene in the ILK-conditional knock-out animal compared to the respective control animal.  
 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
annexin A1 3.44 2.43 5.28 
annexin A2 19.22 16.34 5.30 
annexin A4 2.72 1.55 5.09 
annexin A6 1.82 1.86 1.82 
annexin V 3.44 4.80 5.10 
BCL2-antagonistkiller 
1 (Bak1) 
1.76 1.50 3.50 
Bax 1.64 1.33 2.57 
Bcl-associated death 
promoter (Bad) 
2.49 0.86 7.12 
BH3 interacting 
domain death agonist 
(Bid) 
0.80 0.41 0.51 
caspase 2 1.33 1.67 3.24 
caspase 3 1.32 1.32 27.46 
caspase 7 0.48 0.70 0.45 
caspase 8 0.72 0.84 0.85 
caspase 11 2.73 2.42 3.76 
caspase 12 6.11 4.52 4.09 
cytochrome c oxidase, 
subunit Va 
0.64 0.91 0.43 
cytochrome c oxidase, 
subunit Vb 
0.83 0.67 0.41 
cytochrome c oxidase, 0.62 0.70 1.97 
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subunit VI a, 
polypeptide 2 
cytochrome c oxidase, 
subunit VIc   
0.77 0.74 0.36 
cytochrome c oxidase, 
subunit VIIc   
0.83 0.47 0.55 
LPS-induced TNF-
alpha factor 
2.73 3.10 2.12 
programmed cell 
death 4 
0.59 0.49 0.24 
programmed cell 
death 6 
1.16 0.73 0.75 
PUMA 1.74 2.09 0.65 
tumor necrosis factor 
receptor superfamily, 
member 21 
3.01 1.51 2.12 
tumor necrosis factor 
receptor superfamily, 
member 9 
1.09 0.59 0.62 
ubiquinol-cytochrome 
c reductase core 
protein 1 
0.67 1.93 0.56 
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Table 7. Changes in Signaling pathway-related genes in the ILK conditional knock-out 
animals. The number next to the name of the gene corresponds to the fold increase or decrease of the 
mRNA expression level of that gene in the ILK-conditional knock-out animal compared to the respective 
control animal.  
 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
adenylate cyclase 7 2.32 8.55 2.82 
Cdc42 1.61 1.77 2.52 
dedicator of cyto-
kinesis 2 (Dock2) 
8.25 4.38 5.49 
ELK1 2.59 3.13 4.12 
ELK3 1.99 1.21 5.18 
frizzled homolog 6 1.31 1.43 1.86 
frizzled homolog 2 1.22 0.30 3.96 
Harvey rat sarcoma 
oncogene, subgroup 
R (Rras) 
2.50 2.34 2.64 
inhibitor of kappaB 
kinase gamma 
(Ikbkg) 
2.05 1.48 25.20 
Jun oncogene 1.61 1.79 5.56 
Jun-B oncogene 1.53 1.40 4.87 
MAP2K5 0.40 0.64 1.39 
MAP2K6 0.60 0.49 0.07 
MAP3K5 0.79 0.85 0.69 
Map3k4 1.72 2.67 1.95 
Map4k4 2.24 2.56 5.41 
Map3k14 4.76 0.69 1.28 
MAPK3 2.04 1.70 2.40 
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neuroblastoma ras 
oncogene (Nras) 
1.86 2.31 2.08 
N-myc downstream 
regulated 1 
5.95 2.47 33.90 
N-myc downstream 
regulated 3 
0.66 0.51 0.53 
nuclear factor kappa 
B subunit p100 
(Nfkb2) 
8.70 10.34 7.89 
p21 (CDKN1A)-
activated kinase 1 
(Pak1) 
3.05 2.10 5.07 
protein kinase C, 
epsilon 
0.71 0.66 1.87 
ras homolog 9 
(RhoC) 
5.53 6.49 8.26 
Ras suppressor 
protein 1 (RSU-1) 
1.53 1.44 1.73 
Rho-associated 
coiled-coil forming 
kinase 2 (ROCK2) 
1.22 1.96 2.04 
Rous sarcoma 
oncogene 
4.04 5.72 20.36 
secreted frizzled-
related sequence 
protein 1 
1.58 1.56 2.19 
spleen tyrosine 
kinase (Syk) 
12.93 20.33 6.50 
STAT1 0.63 2.79 0.70 
STAT3 1.72 2.14 3.55 
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STAT5b 0.71 1.60 1.87 
STAT6 1.36 1.99 2.60 
Wnt10a 1.79 1.30 3.28 
Wnt5b 1.55 1.53 0.65 
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 Table 8. Changes in Cytoskeleton-related genes in the ILK conditional knock-out animals. The 
number next to the name of the gene corresponds to the fold increase or decrease of the mRNA 
expression level of that gene in the ILK-conditional knock-out animal compared to the respective control 
animal.  
 
 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
actin, beta, 
cytoplasmic 
1.41 1.77 2.66 
Gelsolin 2.10 3.28 1.62 
Lamin A 3.27 2.11 3.54 
Lamin B1 2.96 1.83 2.00 
microtubule-
associated 
protein tau 
7.46 1.92 16.37 
myocyte 
enhancer factor 
2A 
0.64 0.70 2.02 
myocyte 
enhancer factor 
2B 
0.57 0.87 0.81 
Myosin heavy 
chain IX   
1.64 2.50 9.08 
myosin IC   4.41 1.44 3.05 
myosin IXb 2.65 3.10 1.50 
myosin VIIb 6.39 3.19 1.72 
myosin X   2.27 2.15 3.57 
tropomyosin 1, 
alpha 
4.51 3.24 15.10 
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tropomyosin 3, 
gamma 
1.59 1.85 3.18 
tubulin, alpha 1 2.66 2.69 7.34 
tubulin, beta 5 2.19 3.21 4.23 
Vimentin 5.53 6.05 7.95 
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Table 9. Changes in proteases in the ILK conditional knock-out animals. The number next to 
the name of the gene corresponds to the fold increase or decrease of the mRNA expression level of that 
gene in the ILK-conditional knock-out animal compared to the respective control animal.  
Adamts: a disintegrin-like and metalloprotease with thrombospondin type 1 motif, Adam: a disintegrin 
and metalloprotease domain. 
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
Adam10 5.91 0.56 8.13 
Adam17 0.55 0.63 0.60 
Adamts5 10.64 32.60 14.46 
Adamts8 1.79 0.58 2.04 
calpain 1 10.29 2.19 10.06 
calpain 6 7.37 2.61 3.72 
calpain 7 0.83 0.66 0.61 
calpain 12 0.40 2.13 1.86 
Cathepsin F 0.69 0.74 0.79 
Cathepsin K 1.80 19.80 2.06 
Cathepsin S 3.94 4.28 3.95 
MMP-2 7.20 109.66 6.58 
MMP-7 6.05 2.01 1.35 
MMP-14 5.72 3.06 4.27 
MMP-15 2.81 3.68 1.87 
MMP-19 0.88 0.70 2.70 
MMP-23 12.38 1.73 6.46 
plasminogen activator, 
tissue 
9.88 11.91 9.06 
tissue inhibitor of MMP-3 1.94 3.56 3.57 
Trypsin 2 0.78 0.24 0.15 
urokinase-type 
plasminogen activator 
receptor, type 2 
2.03 2.45 2.18 
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Table 10. Changes in genes encoding adhesion molecules in the ILK conditional knock-out animals. 
The number next to the name of the gene corresponds to the fold increase or decrease of the mRNA 
expression level of that gene in the ILK-conditional knock-out animal compared to the respective control 
animal.  
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
Activated leukocyte 
cell adhesion 
molecule (ALCAM) 
4.11 2.08 8.28 
cadherin 1 3.52 16.43 3.75 
Cadherin 2 0.77 0.87 0.95 
Cadherin 23 
(otocadherin) 
0.78 0.78 0.48 
catenin alpha 1   1.43 2.19 1.80 
Catenin beta 2.21 0.87 4.05 
CEA-related cell 
adhesion molecule 1   
0.48 0.36 0.46 
CEA-related cell 
adhesion molecule 9 
0.71 0.11 2.55 
Claudin 1 3.26 3.14 2.03 
Claudin 2 2.06 1.91 2.94 
Claudin 3 2.02 2.07 2.42 
Claudin 6 1.74 0.34 6.86 
Claudin 7 1.97 1.52 5.14 
Connexin 43 7.14 0.81 2.08 
Gamma parvin 2.23 26.47 7.43 
Integrin-linked 
kinase (ILK) 
0.50 0.50 0.78 
NCAM-1 2.50 2.70 6.27 
selectin, platelet (p-
selectin) ligand 
2.91 2.52 2.23 
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(Selpl) 
tight junction protein 
2 
2.26 1.69 3.90 
Talin 0.53 1.65 2.29 
Vinculin 2.62 2.28 3.12 
vascular cell 
adhesion molecule 1 
(Vcam1) 
15.06 3.68 2.53 
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Table 11. Changes in cell-cycle-related genes in the ILK conditional knock-out animals. The 
number next to the name of the gene corresponds to the fold increase or decrease of the mRNA 
expression level of that gene in the ILK-conditional knock-out animal compared to the respective control 
animal.  
Gene Albumin-Cre+/- 
ILKfl/fl 
AFP-albumin-
Cre+/- ILK fl/fl 
Foxa3-Cre+/-
ILKfl/fl 
Arrestin, beta 2   1.96 2.02 4.64 
Cdc20 2.59 5.46 3.42 
Cdc25a 1.42 2.40 7.77 
Cdc37 0.61 0.50 0.75 
Cdk4 1.39 1.67 1.97 
Cdk5 0.54 0.70 2.07 
cyclin A2 2.58 2.52 1.88 
cyclin B2 2.70 2.24 12.09 
cyclin C 1.82 0.79 0.63 
cyclin G 0.66 0.67 1.65 
cyclin G2 1.47 1.50 2.43 
cyclin I 0.73 0.84 0.71 
cyclin-dependent 
kinase inhibitor 
1A (P21) 
5.59 3.51 10.59 
Gadd45b 1.94 0.21 15.97 
growth arrest 
specific 5 
0.70 0.29 0.43 
growth arrest 
specific 1 
0.76 0.87 0.46 
Ki 67 11.67 2.09 2.08 
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8.0  GENERAL DISCUSSION AND FUTURE DIRECTIONS 
In the present Thesis dissertation, I focused on two major areas of research.  First, I investigated 
the cellular and molecular mechanisms that govern cell-matrix and cell-cell adhesions.  In that 
regard, as described in Chapters 2 and 3, I examined the role of novel cell-matrix adhesion 
proteins in the normal function of the cells.   
 
More sprecifically, in Chapter 2 migfilin is identified not only as a cell-matrix adhesion 
protein but also as a cell-cell adhesion protein.  Moreover, migfilin is shown to be an essential 
component of cell-cell adhesions in endothelial and epithelial cells since depletion of the protein 
leads to compromised organization of the adherens junctions and as a result to a weakened cell-
cell adhession.   
 
Furthermore, in Chapter 3, the role of RSU-1, a newly identified PINCH-binding protein, 
was examined in cell-adhesion-related functions.  RSU-1 is shown to be important in regulating 
cell spreading and Rac activity, functions highly relevant to cell adhesion. 
 
In the second part of my Thesis, I investigated the role of one of the cell-matrix adhesion 
proteins, namely ILK, in the system of hepatocyte differentiation and in liver biology in general.  
As described in Chapter 5, ILK along with PINCH and parvin play an important role during the 
matrix-induced hepatocyte differentiation.   
 
Thus, it is not surprising that removal of ILK either from hepatocytes or from the whole 
liver (Chapters 6 and 7, respectively) has a dramatic effect.  Depletion of ILK from cultured 
hepatocytes in vitro leads to massive apoptosis, clearly showing that ILK is absolutely essential 
for hepatocyte survival.  Furthermore, removal of ILK from the whole animal in vivo, by 
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injecting the ILK-floxed animals with Cre-recombinase-expressing adenovirus, results in 
fulminant hepatitis (Chapter 6).  Last but not least, genetic elimination of the ILK gene 
specifically from the liver by breeding the ILK-floxed animals with AFP-albumin, albumin, or 
Foxa3-Cre trangenics, results in animals whose livers are completely disorganized, fibrotic, with 
many cells that undergo apoptosis, with abnormal mitoses and great diffects in the biliar system 
(Chapter 7).   
 
Taking into account the fact that complete ILK knock-out is embryonic lethal at a stage 
as early as peri-implantation (Sakai et al., 2003), it is not surprising that ILK is proven to be 
critical as well, for a specific organ such as the liver.  The work presented here, clearly 
demonstates the significance of ILK for hepatocyte survival and for maintaining normal liver 
architecture and function, suggesting that liver is greatly dependent upon cell-matrix interactions 
and the signaling pathways that they activate. 
 
Therefore, the present work emphasizes the significance of cell-matrix adhesion proteins 
and their interactions in fundamental cellular processes such as survival, differentiation, cell 
spreading, and cell-cell communication, while it also highlights the importance of such a protein 
(ILK) in the specific biological system of the liver. 
 
However, there are still a few unanswered questions that need to be addressed in the 
future in order to complete our understanding of the molecular mechanism by which each of the 
studied proteins works.  For instance, how does the interaction of PINCH and RSU-1 affect 
different cellular functions? Or, what is the exact mechanism by which ILK exerts its actions in 
the liver?  What is the molecular pathway that gets activated?  What is the series of events that 
leads from the genetic elimination of ILK to the extreme phenotype that we observed?  
 
In conclusion, the present work provides new insight into the role of matrix, cell-matrix 
adhesion proteins and their interactions both in basic cellular function and in application on a 
specific organ system and shows a good correlation between in vitro and in vivo findings.   
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